<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Interventions for cutaneous Bowen's disease - Bath‐Hextall, FJ - 2013 | Cochrane Library</title> <meta content="Interventions for cutaneous Bowen's disease - Bath‐Hextall, FJ - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007281.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Interventions for cutaneous Bowen's disease - Bath‐Hextall, FJ - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007281.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD007281.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Interventions for cutaneous Bowen's disease" name="citation_title"/> <meta content="Fiona J Bath‐Hextall" name="citation_author"/> <meta content="The University of Nottingham" name="citation_author_institution"/> <meta content="fiona.bath-hextall@nottingham.ac.uk" name="citation_author_email"/> <meta content="Rubeta N Matin" name="citation_author"/> <meta content="Churchill Hospital" name="citation_author_institution"/> <meta content="David Wilkinson" name="citation_author"/> <meta content="University of Queensland" name="citation_author_institution"/> <meta content="Jo Leonardi‐Bee" name="citation_author"/> <meta content="The University of Nottingham" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD007281.pub2" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/06/24" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007281.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007281.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007281.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Cryotherapy; *Neoplasm Recurrence, Local; Aminolevulinic Acid [analogs &amp; derivatives, therapeutic use]; Aminoquinolines [therapeutic use]; Antineoplastic Agents [*therapeutic use]; Bowen's Disease [*therapy]; Fluorouracil [therapeutic use]; Imiquimod; Photochemotherapy [*methods]; Photosensitizing Agents [*therapeutic use]; Skin Neoplasms [*therapy]; Treatment Outcome" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007281.pub2&amp;doi=10.1002/14651858.CD007281.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007281.pub2&amp;doi=10.1002/14651858.CD007281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007281.pub2&amp;doi=10.1002/14651858.CD007281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007281.pub2&amp;doi=10.1002/14651858.CD007281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007281.pub2&amp;doi=10.1002/14651858.CD007281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007281.pub2&amp;doi=10.1002/14651858.CD007281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007281.pub2&amp;doi=10.1002/14651858.CD007281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007281.pub2&amp;doi=10.1002/14651858.CD007281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007281.pub2&amp;doi=10.1002/14651858.CD007281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007281.pub2&amp;doi=10.1002/14651858.CD007281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007281.pub2&amp;doi=10.1002/14651858.CD007281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007281.pub2&amp;doi=10.1002/14651858.CD007281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007281.pub2&amp;doi=10.1002/14651858.CD007281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007281.pub2&amp;doi=10.1002/14651858.CD007281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007281.pub2&amp;doi=10.1002/14651858.CD007281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007281.pub2&amp;doi=10.1002/14651858.CD007281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007281.pub2&amp;doi=10.1002/14651858.CD007281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007281.pub2&amp;doi=10.1002/14651858.CD007281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007281.pub2&amp;doi=10.1002/14651858.CD007281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007281.pub2&amp;doi=10.1002/14651858.CD007281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007281.pub2&amp;doi=10.1002/14651858.CD007281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007281.pub2&amp;doi=10.1002/14651858.CD007281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007281.pub2&amp;doi=10.1002/14651858.CD007281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="9mpoajSI";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD007281\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD007281\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007281\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007281\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","hr","fr","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD007281.pub2",title:"Interventions for cutaneous Bowen\u0027s disease",firstPublishedDate:"Jun 24, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Skin Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=9mpoajSI&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007281.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007281.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD007281.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD007281.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007281.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD007281.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD007281.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD007281.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD007281.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD007281.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3133 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD007281.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007281.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007281.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007281.pub2/full#CD007281-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007281.pub2/full#CD007281-sec-0175"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007281.pub2/full#CD007281-sec-0029"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007281.pub2/full#CD007281-sec-0037"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007281.pub2/full#CD007281-sec-0038"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007281.pub2/full#CD007281-sec-0067"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007281.pub2/full#CD007281-sec-0165"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007281.pub2/appendices#CD007281-sec-0180"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/table_n/CD007281StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/table_n/CD007281StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007281.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007281.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007281.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007281.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007281.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD007281.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Interventions for cutaneous Bowen's disease</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007281.pub2/information#CD007281-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Fiona J Bath‐Hextall</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007281.pub2/information#CD007281-cr-0003">Rubeta N Matin</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007281.pub2/information#CD007281-cr-0004">David Wilkinson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007281.pub2/information#CD007281-cr-0005">Jo Leonardi‐Bee</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/information/en#CD007281-sec-0188">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 24 June 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD007281.pub2">https://doi.org/10.1002/14651858.CD007281.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD007281-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007281-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007281-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007281-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007281-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007281-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD007281-abs-0001" lang="en"> <section id="CD007281-sec-0001"> <h3 class="title" id="CD007281-sec-0001">Background</h3> <p>Bowen's disease is the clinical term for in situ squamous cell carcinoma of the skin. Cutaneous lesions present as largely asymptomatic, well‐defined, scaly erythematous patches on sun‐exposed skin. In general, people with Bowen's disease have an excellent prognosis because the disease is typically slow‐growing and responds favourably to treatment. Lesions are persistent and can be progressive, with a small potential (estimated to be 3%) to develop into invasive squamous cell carcinoma. The relative effectiveness of the available treatments is not known for Bowen's disease, and this review attempts to address which is the most effective intervention, with the least side‐effects, for cutaneous Bowen's disease. </p> </section> <section id="CD007281-sec-0002"> <h3 class="title" id="CD007281-sec-0002">Objectives</h3> <p>To assess the effects of therapeutic interventions for cutaneous Bowen's disease.</p> </section> <section id="CD007281-sec-0003"> <h3 class="title" id="CD007281-sec-0003">Search methods</h3> <p>We searched the following databases up to September 2012: the Cochrane Skin Group Specialised Register, CENTRAL in <i>The Cochrane Library</i> (2012, Issue 9), MEDLINE (from 1946), EMBASE (from 1974), PsycINFO (from 1806), and LILACS (from 1982). We also searched online trials registers. We checked the bibliographies of included and excluded studies and reviews, for further references to relevant randomised controlled trials (RCTs). </p> </section> <section id="CD007281-sec-0004"> <h3 class="title" id="CD007281-sec-0004">Selection criteria</h3> <p>We included all randomised controlled trials assessing interventions used in Bowen's disease, preferably histologically proven. </p> </section> <section id="CD007281-sec-0005"> <h3 class="title" id="CD007281-sec-0005">Data collection and analysis</h3> <p>Two authors independently carried out study selection and assessment of methodological quality. </p> </section> <section id="CD007281-sec-0006"> <h3 class="title" id="CD007281-sec-0006">Main results</h3> <p>The primary outcome measures were complete clearance of lesions after the first treatment cycle and recurrence rate at 12 months. Our secondary outcomes included the number of lesions that cleared after each treatment cycle, the number of treatment cycles needed to achieve clearance, the recurrence rates at &gt; 12 months, cosmetic outcome, quality of life assessment, and adverse outcomes as reported by both participant and clinician. </p> <p>We included 9 studies, with a total of 363 participants. One study demonstrated statistically significantly greater clearance of lesions of Bowen's disease with MAL‐PDT (methyl aminolevulinate with photodynamic therapy) when compared with placebo‐PDT (RR (risk ratio) 1.68, 95% CI (confidence interval) 1.12 to 2.52; n = 148) or cryotherapy (RR 1.17, 95% CI 1.01 to 1.37; n = 215), but there was no significant difference when MAL‐PDT was compared to 5‐FU (5‐fluorouracil). One study demonstrated statistically significantly greater clearance of lesions with ALA‐PDT (5‐aminolevulinic acid with photodynamic therapy) versus 5‐FU (RR 1.83, 95% CI 1.10 to 3.06; n = 66), but no statistically significant difference in recurrence rates at 12 months (RR 0.33, 95% CI 0.07 to 1.53). </p> <p>Cryotherapy showed no statistically significant difference in clearance rates (RR 0.99, 95% CI 0.78 to 1.26) or recurrences at 1 year (RR 1.48, 95% CI 0.53 to 4.17) when compared to 5‐FU in 1 study of 127 participants. </p> <p>One study compared imiquimod to placebo and demonstrated statistically significantly greater clearance rates in the imiquimod group (9/15 lesions) compared to placebo (0/16) (Fisher's Exact P value &lt; 0.001). The imiquimod group did not report any recurrences at 12 months, but at 18 months, 2/16 participants in the placebo group had developed early invasive squamous cell carcinoma. </p> </section> <section id="CD007281-sec-0007"> <h3 class="title" id="CD007281-sec-0007">Authors' conclusions</h3> <p>Overall, there has been very little good‐quality research on treatments for Bowen's disease. There is limited evidence from single studies to suggest MAL‐PDT is an effective treatment. Although cosmetic outcomes appear favourable with PDT, five‐year follow‐up data are needed. Significantly more lesions cleared with MAL‐PDT compared to cryotherapy. No significant difference in clearance was seen when MAL‐PDT was compared with 5‐FU, but one study found a significant difference in clearance in favour of ALA‐PDT when compared to 5‐FU. There was no significant difference in clearance when cryotherapy was compared to 5‐FU. </p> <p>The lack of quality data for surgery and topical cream therapies has limited the scope of this review to one largely about PDT studies. The age group, number, and size of lesions and site(s) affected may all influence therapeutic choice; however, there was not enough evidence available to provide guidance on this. More studies are required in the immunosuppressed populations as different therapeutic options may be preferable. Specific recommendations cannot be made from the data in this review, so we cannot give firm conclusions about the comparative effectiveness of treatments. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD007281-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007281-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007281-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007281-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007281-abs-0005">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD007281-abs-0004">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007281-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD007281-abs-0003" lang="en"> <h3>Treatments for cutaneous Bowen's disease</h3> <p>Bowen's disease is the clinical term for a particular precancerous skin lesion. These lesions rarely cause patients any symptoms, but appear as well‐defined scaly patches on sun‐exposed skin, commonly in those over 60 years. They occur more in women and most frequently involve the lower legs of those affected in the UK. It is not known why, but the body sites most commonly affected vary across different countries. In general, people with Bowen's disease have an excellent prognosis because the disease is typically slow to develop and responds favourably to treatment. Lesions are usually slow‐growing, and although they are not life‐threatening, there is a small risk of progression to a skin cancer (estimated to be 3%) known as invasive squamous cell carcinoma. </p> <p>This review attempted to find which is the most effective treatment for cutaneous Bowen's disease, with the least side‐effects. </p> <p>There are a range of treatment options including the following: topical therapies, such as 5‐fluorouracil (5‐FU) and imiquimod creams; surgical interventions, such as excision and Mohs micrographic surgery; destructive therapies, such as cryotherapy (freezing); and light‐based therapies, such as photodynamic therapy (where a light‐sensitive cream is used in combination with visible light). </p> <p>We included 9 randomised controlled trials, with a total of 363 participants. No studies examined surgical methods. </p> <p>Photodynamic therapy appears to be an effective treatment and has the benefit of minimal scarring compared with cryotherapy or 5‐fluorouracil. Cryotherapy is convenient and less expensive, but does not appear to be as effective as photodynamic therapy and results in more scarring; 5‐aminolevulinic acid with photodynamic therapy (ALA‐PDT) appears to be more effective than 5‐fluorouracil, whereas methyl aminolevulinate with photodynamic therapy (MAL‐PDT) does not appear to be as good as 5‐fluorouracil. One study demonstrated benefit with imiquimod cream. </p> <p>Specific recommendations cannot be made from these data, so this review cannot give firm conclusions about the comparative effectiveness of treatments. There is a clear need for future research to focus on a range of different studies comparing various therapies with each other, and in particular to surgical treatments to provide high‐quality evidence to guide clinical practice. The age group, number and size of lesions, sites affected, and immunological status may all influence therapeutic choices. Longer‐term follow up (up to 10 years) is needed to determine the effect of treatments on risk of progression of lesions of Bowen's disease to squamous cell carcinoma. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD007281-sec-0175" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD007281-sec-0175"></div> <h3 class="title" id="CD007281-sec-0176">Implications for practice</h3> <section id="CD007281-sec-0176"> <p>There is only limited quality data available to guide clinical practice. Clinicians need to carefully consider the needs of individuals, characteristics, sites of the lesions, and any comorbidities. Some people may not require any treatment at al; others will benefit from either surgical excision, other destructive treatments, cryotherapy, or topical treatments such as 5‐fluorouracil or photodynamic therapy. Photodynamic therapy appears to be an effective and safe non‐scarring treatment, which should be considered if available. The limited data suggest that 5‐fluorouracil is as effective as PDT, that cryotherapy is possibly less effective than PDT, and that imiquimod is also effective, but has not been compared with PDT. Cost, likely adverse events, and patient preference will all play a part in the choice of treatment. </p> </section> <h3 class="title" id="CD007281-sec-0177">Implications for research</h3> <section id="CD007281-sec-0177"> <p>The lack of good‐quality research on common treatments for Bowen's disease has influenced this review towards PDT studies. There is a clear need for a range of different studies comparing various therapies with each other and potentially with placebo, in order to provide high‐quality evidence to guide clinical practice. In particular, studies comparing interventions to surgical treatments are lacking, for example, quality RCTs comparing surgery with topical treatments, topical treatments with each other, e.g. 5‐fluorouracil with imiquimod, and topical treatments versus PDT, e.g. imiquimod with PDT. </p> <p>Although there is evidence that imiquimod is an effective treatment, studies comparing this intervention to other standard therapies are needed. With these data, we have been unable to stratify treatments according to lesion size, site, or number because of the small numbers of participants. Larger studies are therefore required to better provide guidance to clinicians. Finally, one study reported increased development of squamous cell carcinoma (SCC) in the placebo‐treated group suggesting that treatment may reduce the risk of progression from Bowen's disease. None of the other studies attempted to assess impact of the intervention on progression to SCC, and future studies should consider this as a clinically important outcome. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD007281-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD007281-sec-0029"></div> <p>Please note that we have explained unfamiliar terms in <a href="#CD007281-tbl-0001">Table 1</a>. </p> <div class="table" id="CD007281-tbl-0001"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Glossary of terms</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Medical term</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Explanation</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Metastasis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The spread of a malignant tumour from its original site to another part of the body, e.g. lungs, lymph nodes, liver, brain, bones, etc </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Epidermis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The outermost layer of the skin</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Transformation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A process by which cells acquire the properties of cancer</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Subungual</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Underneath the nail (finger or toe)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Periungual</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Around the nail</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Carcinogen</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This is any substance, radionuclide, or radiation that is an agent directly involved in causing cancer </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HPV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human papillomavirus</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TH1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>T‐helper cells 1</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>T cell</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A type of white blood cell</p> </td> </tr> </tbody> </table> </div> <section id="CD007281-sec-0030"> <h3 class="title" id="CD007281-sec-0030">Description of the condition</h3> <p>John Templeton Bowen first described Bowen's disease in 1912 (<a href="./references#CD007281-bbs2-0023" title="AliH , ShipmanAR , OrpinSD . John Templeton Bowen, MD, 1857–1940: the centenary of his most famous publication. Clinical and Experimental DermatologyOctober 2012;37(7):825‐828. [PUBMED: 22998547] ">Ali 2012</a>). It is the clinical term for in situ squamous cell carcinoma, a type of non‐melanoma skin cancer (NMSC) that is confined to the epidermis (<a href="./references#CD007281-bbs2-0024" title="ArletteJP , TrotterMJ . Squamous cell carcinoma in situ of the skin: history, presentation, biology and treatment. Australasian Journal of Dermatology2004;45(1):1‐10. [MEDLINE: 14961900] ">Arlette 2004</a>). Typically, Bowen's disease lesions are slow‐growing, non‐pigmented reddish patches with irregular edges and a yellow or white crusting or scaling surface (<a href="./references#CD007281-bbs2-0024" title="ArletteJP , TrotterMJ . Squamous cell carcinoma in situ of the skin: history, presentation, biology and treatment. Australasian Journal of Dermatology2004;45(1):1‐10. [MEDLINE: 14961900] ">Arlette 2004</a>; <a href="./references#CD007281-bbs2-0028" title="CoxNH , EedyDJ , MortonCA . Guidelines for management of Bowen's disease. British Association of Dermatologists. British Journal of Dermatology1999;141(4):633‐41. [MEDLINE: 10583109] ">Cox 1999</a>; <a href="./references#CD007281-bbs2-0043" title="RagiG , TurnerMS , KleinLE , StollHL . Pigmented Bowen's disease and review of 420 Bowen's disease lesions. Journal of Dermatologic Surgery &amp; Oncology1988;14(7):765‐9. [MEDLINE: 3292613] ">Ragi 1988</a>). They are clearly demarcated from the surrounding normal skin. They are generally asymptomatic, although larger lesions may itch (<a href="./references#CD007281-bbs2-0024" title="ArletteJP , TrotterMJ . Squamous cell carcinoma in situ of the skin: history, presentation, biology and treatment. Australasian Journal of Dermatology2004;45(1):1‐10. [MEDLINE: 14961900] ">Arlette 2004</a>). Lesions are usually solitary, but multiple lesions occur in 10% to 20% of individuals (<a href="./references#CD007281-bbs2-0030" title="EedyDJ , GavinAT . Thirteen‐year retrospective study of Bowen's disease in Northern Ireland. British Journal of Dermatology1987;117(6):715‐20. [MEDLINE: 3426952] ">Eedy 1987</a>; <a href="./references#CD007281-bbs2-0039" title="KovacsA , YonemotoK , KatsuokaK , NishiyamaS , HarhaiI . Bowen's disease: statistical study of a 10 year period. Journal of Dermatology1996;23(4):267‐74. [MEDLINE: 8935343] ">Kovacs 1996</a>; <a href="./references#CD007281-bbs2-0046" title="Thestrup‐PedersenK , RavnborgL , ReymannF . Morbus Bowen. A description of the disease in 617 patients. Acta Dermato‐Venereologica1988;68(3):236‐9. [MEDLINE: 2455417] ">Thestrup‐Pedersen 1988</a>). Lesion size varies considerably, from a few millimetres to several centimetres in diameter, with the size of the lesion being directly related to its duration (<a href="./references#CD007281-bbs2-0024" title="ArletteJP , TrotterMJ . Squamous cell carcinoma in situ of the skin: history, presentation, biology and treatment. Australasian Journal of Dermatology2004;45(1):1‐10. [MEDLINE: 14961900] ">Arlette 2004</a>). The lesions are usually persistent and progressive and have a small potential for invasive malignancy. </p> <section id="CD007281-sec-0031"> <h4 class="title">Incidence and demographics</h4> <p>Bowen's disease can occur at any age in adults, although large‐population cohort studies suggest that it is commonly diagnosed in older people, between 60 and 90 years (<a href="./references#CD007281-bbs2-0030" title="EedyDJ , GavinAT . Thirteen‐year retrospective study of Bowen's disease in Northern Ireland. British Journal of Dermatology1987;117(6):715‐20. [MEDLINE: 3426952] ">Eedy 1987</a>; <a href="./references#CD007281-bbs2-0035" title="JaegerAB , GramkowA , HjalgrimH , MelbyeM , FrischM . Bowen disease and risk of subsequent malignant neoplasms: a population‐based cohort study of 1147 patients. Archives of Dermatology1999;135(7):790‐3. [MEDLINE: 10411153] ">Jaeger 1999</a>; <a href="./references#CD007281-bbs2-0038" title="KossardS , RosenR . Cutaneous Bowen's disease. An analysis of 1001 cases according to age, sex, and site. Journal of the American Academy of Dermatology1992;27(3):406‐10. [MEDLINE: 1401276] ">Kossard 1992</a>; <a href="./references#CD007281-bbs2-0039" title="KovacsA , YonemotoK , KatsuokaK , NishiyamaS , HarhaiI . Bowen's disease: statistical study of a 10 year period. Journal of Dermatology1996;23(4):267‐74. [MEDLINE: 8935343] ">Kovacs 1996</a>; <a href="./references#CD007281-bbs2-0044" title="ReiznerGT , ChuangTY , ElpernDJ , StoneJL , FarmerER . Bowen's disease (squamous cell carcinoma in situ) in Kauai, Hawaii. A population‐based incidence report. Journal of the American Academy of Dermatology1994;31(4):596‐600. [MEDLINE: 8089285] ">Reizner 1994</a>; <a href="./references#CD007281-bbs2-0046" title="Thestrup‐PedersenK , RavnborgL , ReymannF . Morbus Bowen. A description of the disease in 617 patients. Acta Dermato‐Venereologica1988;68(3):236‐9. [MEDLINE: 2455417] ">Thestrup‐Pedersen 1988</a>). These studies also reveal considerable worldwide variation in gender and body site distribution. Generally, Bowen's disease occurs more commonly in women, and varies in frequency between countries. In an Australian study, 57% of those with the disease were women (<a href="./references#CD007281-bbs2-0038" title="KossardS , RosenR . Cutaneous Bowen's disease. An analysis of 1001 cases according to age, sex, and site. Journal of the American Academy of Dermatology1992;27(3):406‐10. [MEDLINE: 1401276] ">Kossard 1992</a>); 56% to 61%, in 2 Danish studies (<a href="./references#CD007281-bbs2-0035" title="JaegerAB , GramkowA , HjalgrimH , MelbyeM , FrischM . Bowen disease and risk of subsequent malignant neoplasms: a population‐based cohort study of 1147 patients. Archives of Dermatology1999;135(7):790‐3. [MEDLINE: 10411153] ">Jaeger 1999</a>; <a href="./references#CD007281-bbs2-0046" title="Thestrup‐PedersenK , RavnborgL , ReymannF . Morbus Bowen. A description of the disease in 617 patients. Acta Dermato‐Venereologica1988;68(3):236‐9. [MEDLINE: 2455417] ">Thestrup‐Pedersen 1988</a>); 54%, in a Japanese study (<a href="./references#CD007281-bbs2-0039" title="KovacsA , YonemotoK , KatsuokaK , NishiyamaS , HarhaiI . Bowen's disease: statistical study of a 10 year period. Journal of Dermatology1996;23(4):267‐74. [MEDLINE: 8935343] ">Kovacs 1996</a>); 74% to 80%, in 2 studies in the UK (<a href="./references#CD007281-bbs2-0027" title="CoxNH . Body site distribution of Bowen's disease. British Journal of Dermatology1994;130(6):714‐6. [MEDLINE: 8011495] ">Cox 1994</a>; <a href="./references#CD007281-bbs2-0030" title="EedyDJ , GavinAT . Thirteen‐year retrospective study of Bowen's disease in Northern Ireland. British Journal of Dermatology1987;117(6):715‐20. [MEDLINE: 3426952] ">Eedy 1987</a>); and 63%, in a study from the USA (<a href="./references#CD007281-bbs2-0044" title="ReiznerGT , ChuangTY , ElpernDJ , StoneJL , FarmerER . Bowen's disease (squamous cell carcinoma in situ) in Kauai, Hawaii. A population‐based incidence report. Journal of the American Academy of Dermatology1994;31(4):596‐600. [MEDLINE: 8089285] ">Reizner 1994</a>). The exception was in a study of a white population in Hawaii, where only 38% were women (<a href="./references#CD007281-bbs2-0044" title="ReiznerGT , ChuangTY , ElpernDJ , StoneJL , FarmerER . Bowen's disease (squamous cell carcinoma in situ) in Kauai, Hawaii. A population‐based incidence report. Journal of the American Academy of Dermatology1994;31(4):596‐600. [MEDLINE: 8089285] ">Reizner 1994</a>). </p> <p>Although few studies have calculated incidence rates, there is considerable variation between the rates reported in America: 15 per 100,000 in Minneapolis (<a href="./references#CD007281-bbs2-0026" title="ChuteCG , ChuangTY , BergstralhEJ , SuWP . The subsequent risk of internal cancer with Bowen's disease. A population‐based study. JAMA1991;266(6):816‐9. [MEDLINE: 1865520] ">Chute 1991</a>), 28 per 100,000 for men and 22 per 100,000 for women in Canada (<a href="./references#CD007281-bbs2-0024" title="ArletteJP , TrotterMJ . Squamous cell carcinoma in situ of the skin: history, presentation, biology and treatment. Australasian Journal of Dermatology2004;45(1):1‐10. [MEDLINE: 14961900] ">Arlette 2004</a>), and 174 per 100,000 for white men and 115 per 100,000 for white women living in Hawaii (<a href="./references#CD007281-bbs2-0044" title="ReiznerGT , ChuangTY , ElpernDJ , StoneJL , FarmerER . Bowen's disease (squamous cell carcinoma in situ) in Kauai, Hawaii. A population‐based incidence report. Journal of the American Academy of Dermatology1994;31(4):596‐600. [MEDLINE: 8089285] ">Reizner 1994</a>). </p> <p>In Australia, the most common sites of Bowen's disease lesions are the head and neck (44%), followed by the lower limbs (30%), with 70% of lesions occurring below the knee. Australian men most commonly have lesions on the head and neck, while Australian women more commonly have Bowen's disease lesions on their lower limbs (<a href="./references#CD007281-bbs2-0038" title="KossardS , RosenR . Cutaneous Bowen's disease. An analysis of 1001 cases according to age, sex, and site. Journal of the American Academy of Dermatology1992;27(3):406‐10. [MEDLINE: 1401276] ">Kossard 1992</a>). The head and neck regions were also the most common site for lesions: in Denmark they made up 59% in 1 study (<a href="./references#CD007281-bbs2-0046" title="Thestrup‐PedersenK , RavnborgL , ReymannF . Morbus Bowen. A description of the disease in 617 patients. Acta Dermato‐Venereologica1988;68(3):236‐9. [MEDLINE: 2455417] ">Thestrup‐Pedersen 1988</a>) and 40% in another (<a href="./references#CD007281-bbs2-0035" title="JaegerAB , GramkowA , HjalgrimH , MelbyeM , FrischM . Bowen disease and risk of subsequent malignant neoplasms: a population‐based cohort study of 1147 patients. Archives of Dermatology1999;135(7):790‐3. [MEDLINE: 10411153] ">Jaeger 1999</a>), whereas in the USA they made up 66% (<a href="./references#CD007281-bbs2-0044" title="ReiznerGT , ChuangTY , ElpernDJ , StoneJL , FarmerER . Bowen's disease (squamous cell carcinoma in situ) in Kauai, Hawaii. A population‐based incidence report. Journal of the American Academy of Dermatology1994;31(4):596‐600. [MEDLINE: 8089285] ">Reizner 1994</a>). Reports from the UK suggest a different pattern of distribution of lesions: 13% of lesions on the head and neck (<a href="./references#CD007281-bbs2-0030" title="EedyDJ , GavinAT . Thirteen‐year retrospective study of Bowen's disease in Northern Ireland. British Journal of Dermatology1987;117(6):715‐20. [MEDLINE: 3426952] ">Eedy 1987</a>) and 60% to 85% on the lower limbs (<a href="./references#CD007281-bbs2-0027" title="CoxNH . Body site distribution of Bowen's disease. British Journal of Dermatology1994;130(6):714‐6. [MEDLINE: 8011495] ">Cox 1994</a>; <a href="./references#CD007281-bbs2-0030" title="EedyDJ , GavinAT . Thirteen‐year retrospective study of Bowen's disease in Northern Ireland. British Journal of Dermatology1987;117(6):715‐20. [MEDLINE: 3426952] ">Eedy 1987</a>). Generally, few Bowen's disease lesions occur on the trunk, but a study in Japan (<a href="./references#CD007281-bbs2-0039" title="KovacsA , YonemotoK , KatsuokaK , NishiyamaS , HarhaiI . Bowen's disease: statistical study of a 10 year period. Journal of Dermatology1996;23(4):267‐74. [MEDLINE: 8935343] ">Kovacs 1996</a>) and another on white people living in Hawaii (<a href="./references#CD007281-bbs2-0044" title="ReiznerGT , ChuangTY , ElpernDJ , StoneJL , FarmerER . Bowen's disease (squamous cell carcinoma in situ) in Kauai, Hawaii. A population‐based incidence report. Journal of the American Academy of Dermatology1994;31(4):596‐600. [MEDLINE: 8089285] ">Reizner 1994</a>) found a notably higher predominance of lesions on the trunk: 35% and 26%, respectively. </p> <p>Other less common sites and variants include pigmented Bowen's disease, subungual/periungual, palmar, genital, and verrucous Bowen's disease. </p> </section> <section id="CD007281-sec-0032"> <h4 class="title">Impact</h4> <p>In general, people with Bowen's disease have an excellent prognosis because the disease is typically slow‐growing and responds favourably to treatment, although a significant number of lesions of Bowen's disease are not treated due to its relatively benign nature and the demographics of the participants with the condition. The risk of progression of Bowen's disease to invasive squamous cell carcinoma (SCC) is generally considered to be about 3% (<a href="./references#CD007281-bbs2-0037" title="KaoGF . Carcinoma arising in Bowen's disease. Archives of Dermatology1986;122(10):1124‐6. [MEDLINE: 3767398] ">Kao 1986</a>; <a href="./references#CD007281-bbs2-0041" title="PeterkaES , LynchFW , GoltzRW . An association between Bowen's disease and internal cancer. Archives of Dermatology1961;84:623‐9. [MEDLINE: 14485715] ">Peterka 1961</a>), of which approximately one third may metastasise (<a href="./references#CD007281-bbs2-0024" title="ArletteJP , TrotterMJ . Squamous cell carcinoma in situ of the skin: history, presentation, biology and treatment. Australasian Journal of Dermatology2004;45(1):1‐10. [MEDLINE: 14961900] ">Arlette 2004</a>; <a href="./references#CD007281-bbs2-0028" title="CoxNH , EedyDJ , MortonCA . Guidelines for management of Bowen's disease. British Association of Dermatologists. British Journal of Dermatology1999;141(4):633‐41. [MEDLINE: 10583109] ">Cox 1999</a>). These figures are high compared to what is actually seen in clinical practice and may reflect the inclusion of mucosal and anogenital Bowen's disease, where there is a higher risk of transformation and metastasis. </p> <p>Bowen's disease may represent a risk marker for other non‐melanoma skin cancers. Studies that have investigated this association report that about one third of people have another NMSC (non‐melanoma skin cancer), most commonly basal cell carcinomas (BCC), at the time of diagnosis (<a href="./references#CD007281-bbs2-0044" title="ReiznerGT , ChuangTY , ElpernDJ , StoneJL , FarmerER . Bowen's disease (squamous cell carcinoma in situ) in Kauai, Hawaii. A population‐based incidence report. Journal of the American Academy of Dermatology1994;31(4):596‐600. [MEDLINE: 8089285] ">Reizner 1994</a>; <a href="./references#CD007281-bbs2-0046" title="Thestrup‐PedersenK , RavnborgL , ReymannF . Morbus Bowen. A description of the disease in 617 patients. Acta Dermato‐Venereologica1988;68(3):236‐9. [MEDLINE: 2455417] ">Thestrup‐Pedersen 1988</a>). There is also 4.3 times more risk of developing subsequent NMSC, which most likely reflects the shared ultraviolet light radiation aetiology (<a href="./references#CD007281-bbs2-0035" title="JaegerAB , GramkowA , HjalgrimH , MelbyeM , FrischM . Bowen disease and risk of subsequent malignant neoplasms: a population‐based cohort study of 1147 patients. Archives of Dermatology1999;135(7):790‐3. [MEDLINE: 10411153] ">Jaeger 1999</a>). </p> <p>There has been much discussion about an association between Bowen's disease and internal malignancies, with several studies suggesting a significant relationship (summarised in <a href="./references#CD007281-bbs2-0028" title="CoxNH , EedyDJ , MortonCA . Guidelines for management of Bowen's disease. British Association of Dermatologists. British Journal of Dermatology1999;141(4):633‐41. [MEDLINE: 10583109] ">Cox 1999</a>). However, a 1989 meta‐analysis of 12 studies (10 cohort and 2 case‐control studies) found no significant relationship between Bowen's disease and internal malignancies (<a href="./references#CD007281-bbs2-0040" title="LyckaBA . Bowen's disease and internal malignancy. A meta‐analysis. International Journal of Dermatology1989;28(8):531‐3. [MEDLINE: 2684878] ">Lycka 1989</a>). This result was subsequently confirmed by two large population‐based cohort studies in Denmark (<a href="./references#CD007281-bbs2-0035" title="JaegerAB , GramkowA , HjalgrimH , MelbyeM , FrischM . Bowen disease and risk of subsequent malignant neoplasms: a population‐based cohort study of 1147 patients. Archives of Dermatology1999;135(7):790‐3. [MEDLINE: 10411153] ">Jaeger 1999</a>) and in the USA. It is now generally accepted that there is no relationship between Bowen's disease and internal malignancies, and routine investigation for internal malignancies is not justified (<a href="./references#CD007281-bbs2-0029" title="CoxNH , EedyDJ , MortonCA , Therapy Guidelines and Audit Subcommittee, British Association of Dermatologists. Guidelines for management of Bowen's disease: 2006 update. British Journal of Dermatology2007;156(1):11‐21. [MEDLINE: 17199561] ">Cox 2007</a>). </p> </section> <section id="CD007281-sec-0033"> <h4 class="title">Causes</h4> <p>Bowen's disease predominantly occurs in older age groups and on areas of the body subjected to chronic sun exposure (head and neck, and lower legs in women), suggesting a causal relationship between chronic exposure to ultraviolet light radiation and Bowen's disease (<a href="./references#CD007281-bbs2-0027" title="CoxNH . Body site distribution of Bowen's disease. British Journal of Dermatology1994;130(6):714‐6. [MEDLINE: 8011495] ">Cox 1994</a>; <a href="./references#CD007281-bbs2-0030" title="EedyDJ , GavinAT . Thirteen‐year retrospective study of Bowen's disease in Northern Ireland. British Journal of Dermatology1987;117(6):715‐20. [MEDLINE: 3426952] ">Eedy 1987</a>; <a href="./references#CD007281-bbs2-0038" title="KossardS , RosenR . Cutaneous Bowen's disease. An analysis of 1001 cases according to age, sex, and site. Journal of the American Academy of Dermatology1992;27(3):406‐10. [MEDLINE: 1401276] ">Kossard 1992</a>; <a href="./references#CD007281-bbs2-0039" title="KovacsA , YonemotoK , KatsuokaK , NishiyamaS , HarhaiI . Bowen's disease: statistical study of a 10 year period. Journal of Dermatology1996;23(4):267‐74. [MEDLINE: 8935343] ">Kovacs 1996</a>; <a href="./references#CD007281-bbs2-0044" title="ReiznerGT , ChuangTY , ElpernDJ , StoneJL , FarmerER . Bowen's disease (squamous cell carcinoma in situ) in Kauai, Hawaii. A population‐based incidence report. Journal of the American Academy of Dermatology1994;31(4):596‐600. [MEDLINE: 8089285] ">Reizner 1994</a>; <a href="./references#CD007281-bbs2-0046" title="Thestrup‐PedersenK , RavnborgL , ReymannF . Morbus Bowen. A description of the disease in 617 patients. Acta Dermato‐Venereologica1988;68(3):236‐9. [MEDLINE: 2455417] ">Thestrup‐Pedersen 1988</a>). Exposure to carcinogens, e.g. arsenic through well water, older medications, and occupational chemicals, have been associated with the development of Bowen's disease. A time lag of more than 10 years between exposure and development of lesions is typical (<a href="./references#CD007281-bbs2-0024" title="ArletteJP , TrotterMJ . Squamous cell carcinoma in situ of the skin: history, presentation, biology and treatment. Australasian Journal of Dermatology2004;45(1):1‐10. [MEDLINE: 14961900] ">Arlette 2004</a>; <a href="./references#CD007281-bbs2-0028" title="CoxNH , EedyDJ , MortonCA . Guidelines for management of Bowen's disease. British Association of Dermatologists. British Journal of Dermatology1999;141(4):633‐41. [MEDLINE: 10583109] ">Cox 1999</a>). Viral aetiology has been postulated. The role of human herpes virus 8 (HHV8) is unclear. </p> <p>In contrast, there is excellent evidence for a causative role for alpha‐papillomaviruses (mucosal HPV types) in periungual Bowen's and in mucosal and anogenital Bowen's disease, although the frequency with which these agents are detected in these lesions varies (<a href="./references#CD007281-bbs2-0029" title="CoxNH , EedyDJ , MortonCA , Therapy Guidelines and Audit Subcommittee, British Association of Dermatologists. Guidelines for management of Bowen's disease: 2006 update. British Journal of Dermatology2007;156(1):11‐21. [MEDLINE: 17199561] ">Cox 2007</a>; <a href="./references#CD007281-bbs2-0032" title="GrundmeierN , HammH , WeissbrichB , LangSC , BröckerEB , KerstanA . High‐risk human papillomavirus infection in Bowen's disease of the nail unit: report of three cases and review of the literature. Dermatology2011;223(4):293‐300. [MEDLINE: 22269697] ">Grundmeier 2011</a>; <a href="./references#CD007281-bbs2-0045" title="RiddelC , RashidR , ThomasV . Ungual and periungual human papillomavirus‐associated squamous cell carcinoma: a review. Journal of the American Academy of Dermatology2011;64(6):1147‐53. [MEDLINE: 21315482] ">Riddel 2011</a>). </p> <p>Although not the subject of this review, mucosal HPV types are implicated in almost 100% of cases of mucosal and anogenital Bowen's disease (<a href="./references#CD007281-bbs2-0034" title="IftnerA , KlugSJ , GarbeC , BlumA , StancuA , WilczynskiSP , et al. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high‐risk genital types as possible risk factors. Cancer Research2003;63(21):7515‐9. [MEDLINE: 14612553] ">Iftner 2003</a>). </p> <p>Immunosuppression, either congenital, acquired, or iatrogenic, has also been associated with Bowen's disease (<a href="./references#CD007281-bbs2-0025" title="BordeaC , WojnarowskaF , MillardPR , DollH , WelshK , MorrisPJ . Skin cancers in renal‐transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation2004;77(4):574‐9. [MEDLINE: 15084938] ">Bordea 2004</a>; <a href="./references#CD007281-bbs2-0028" title="CoxNH , EedyDJ , MortonCA . Guidelines for management of Bowen's disease. British Association of Dermatologists. British Journal of Dermatology1999;141(4):633‐41. [MEDLINE: 10583109] ">Cox 1999</a>; <a href="./references#CD007281-bbs2-0031" title="EedyDJ . Summary of inaugural meeting of the Skin Care in Organ Recipients Group, UK, held at the Royal Society of Medicine, 7 October 2004. British Journal of Dermatology2005;153(1):6‐10. [MEDLINE: 16029319] ">Eedy 2005</a>; <a href="./references#CD007281-bbs2-0007" title="PerrettCM , McGregorJM , WarwickJ , KarranP , LeighIM , ProbyCM , et al. Treatment of post‐transplant premalignant skin disease: a randomised intrapatient comparative study of 5‐fluorouracil cream and topical photodynamic therapy. British Journal of Dermatology2007;156(2):320‐8. [MEDLINE: 17223873] ">Perrett 2007</a>). One study demonstrated that 23% of skin cancers in renal transplant recipients were Bowen's disease (<a href="./references#CD007281-bbs2-0025" title="BordeaC , WojnarowskaF , MillardPR , DollH , WelshK , MorrisPJ . Skin cancers in renal‐transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation2004;77(4):574‐9. [MEDLINE: 15084938] ">Bordea 2004</a>). </p> </section> </section> <section id="CD007281-sec-0034"> <h3 class="title" id="CD007281-sec-0034">Description of the intervention</h3> <p>There are a range of treatment options for Bowen's disease, including the following:</p> <p> <ul id="CD007281-list-0001"> <li> <p>topical therapies, such as 5‐fluorouracil and imiquimod creams;</p> </li> <li> <p>surgical interventions, such as excision and Mohs micrographic surgery;</p> </li> <li> <p>destructive therapies, such as cryotherapy and curettage and cautery,</p> </li> <li> <p>light‐based therapies, such as laser therapy and photodynamic therapy; and</p> </li> <li> <p>radiotherapy.</p> </li> </ul> </p> </section> <section id="CD007281-sec-0035"> <h3 class="title" id="CD007281-sec-0035">How the intervention might work</h3> <p>The primary mechanism of action of 5‐fluorouracil is inhibition of DNA synthesis by competitive inhibition of thymidylate synthetase and incorporation into RNA and DNA. </p> <p>Imiquimod is an immune‐response modifier that promotes a TH1‐driven cell‐mediated immune response. </p> <p>Mohs micrographic surgery is a technique whereby 100% of the surgical margin is examined by mapping horizontal frozen sections from successive excision layers until complete clearance is achieved. </p> <p>Cryotherapy uses liquid nitrogen to destroy tissue by freezing it to ‐196°C.</p> <p>Electrodessication and cautery and curettage are generally known as 'scraping or burning‐off of skin growths'. Curettage is performed under local anaesthesia. The curette is either an oval, semisharp spoon‐shaped instrument or an open ring connected to a handle. The curette is designed to cut through abnormally soft or friable tissue with minimum force so that the diseased tissue can be selectively removed. Curettage should be combined with subsequent electrocautery that destroys additional tissue. </p> <p>Laser surgery uses a highly focused beam of light that destroys only the cancer cells.</p> <p>Photodynamic therapy is a visible light in the blue or red spectrum that is absorbed by a porphyrin or other light‐sensitive compound, in order to produce free radicals. These free radicals are what cause the cell damage and death. </p> <p>Radiotherapy works by destroying the cancer cells in the treated area using high‐energy X‐rays and has included contact radiation, grenz ray therapy, strontium 90, proton radiotherapy, emitting radionuclides, orthovoltage therapy, and electrons. </p> </section> <section id="CD007281-sec-0036"> <h3 class="title" id="CD007281-sec-0036">Why it is important to do this review</h3> <p>The relative effectiveness of the available treatments for Bowen's disease is not known. The rationale for treatment is to prevent progression to a cancerous lesion and also to improve cosmetic appearance. Treatment of Bowen's disease needs to balance the burden of treatment against its benefit, particularly as the disease mainly affects the elderly and is predominantly slow‐growing in nature with a good prognosis. Some Bowen's disease lesions may deserve special consideration, for example, lesions of the lower limb and especially larger lesions, because of the potential for poor healing in the former and the high recurrence rates in the latter. </p> <p>Given these issues, this review attempted to address the following:</p> <p>(1) What are the most effective treatments for Bowen's disease, with the fewest side‐effects?</p> <p>(2) How do the various therapies compare in the following participant subgroups:</p> <p> <ul id="CD007281-list-0002"> <li> <p>participants with lower leg lesions (i.e. located below the knee)?</p> </li> <li> <p>participants with lesions &gt; 2 cm²?</p> </li> <li> <p>participants with medical comorbidities leading to poor wounding healing, age greater than 70 years, or both? </p> </li> </ul> </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD007281-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD007281-sec-0037"></div> <p>To assess the effects of therapeutic interventions for cutaneous Bowen's disease.</p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD007281-sec-0038" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD007281-sec-0038"></div> <section id="CD007281-sec-0039"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD007281-sec-0040"> <h4 class="title">Types of studies</h4> <p>All randomised controlled trials (RCTs) of any design of interventions for cutaneous Bowen's disease. </p> </section> <section id="CD007281-sec-0041"> <h4 class="title">Types of participants</h4> <p>All adults with histologically proven cutaneous Bowen's disease. We excluded people with genodermatoses (genetic disorders of the skin), mucosal, or anogenital Bowen's disease. </p> </section> <section id="CD007281-sec-0042"> <h4 class="title">Types of interventions</h4> <p>Any interventions for the treatment of cutaneous Bowen's disease, including the following:</p> <p> <ul id="CD007281-list-0003"> <li> <p>Surgical</p> </li> </ul> <ul class="plain" id="CD007281-list-0004"> <li> <ol id="CD007281-list-0005"> <li> <p>Surgical excision</p> </li> <li> <p>Mohs micrographic surgery</p> </li> </ol> </li> </ul> <ul id="CD007281-list-0006"> <li> <p>Destructive</p> </li> </ul> <ul class="plain" id="CD007281-list-0007"> <li> <ol id="CD007281-list-0008"> <li> <p>Curettage, cautery, or electrodesiccation</p> </li> <li> <p>Cryosurgery ‐ any number of cycles</p> </li> </ol> </li> </ul> <ul id="CD007281-list-0009"> <li> <p>Other techniques</p> </li> </ul> <ul class="plain" id="CD007281-list-0010"> <li> <ol id="CD007281-list-0011"> <li> <p>Topical therapy, e.g. imiquimod, 5‐fluorouracil</p> </li> <li> <p>Photodynamic therapy</p> </li> <li> <p>Laser surgery</p> </li> <li> <p>Radiotherapy</p> </li> </ol> </li> </ul> </p> <p>The comparators were any other type of accepted and commonly used treatment method, any interventions compared to control (placebo/no treatment), or different dosages/durations of the same interventions. </p> </section> <section id="CD007281-sec-0043"> <h4 class="title">Types of outcome measures</h4> <section id="CD007281-sec-0044"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD007281-list-0012"> <li> <p>Complete clearance of the lesion.</p> </li> </ol> </p> <p>(a) Number of lesions or participants cleared after first treatment cycle.<br/> (b) Recurrence at 12 months. </p> </section> <section id="CD007281-sec-0045"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD007281-list-0013"> <li> <p>Number of lesions that cleared after each treatment cycle.</p> </li> <li> <p>Number of treatment cycles needed to achieve clearance.</p> </li> <li> <p>Recurrence at &gt; 12 months.</p> </li> <li> <p>Cosmetic outcome using a recognised and validated instrument to measure cosmesis.</p> </li> <li> <p>Consumer satisfaction with treatment modality, cosmesis, or pain at site, recorded on a Likert or Likert‐like scale. </p> </li> <li> <p>Time to complete healing of lesion following treatment, by clinical examination or by participant assessment through a diary or similar mechanism. </p> </li> <li> <p>Quality of life, by any validated quality‐of‐life instrument.</p> </li> <li> <p>Adverse outcomes categorised using the following system: none; mild (transient, requires no treatment, non‐interference with social or occupational function); moderate (requires simple treatment, interferes with social or occupational function); or severe (requires vigorous treatment, hospitalisation, and interrupts social or occupational function). </p> </li> <li> <p>Recurrence of Bowen's disease in same site determined by clinical examination.</p> </li> </ol> </p> </section> </section> </section> <section id="CD007281-sec-0046"> <h3 class="title">Search methods for identification of studies</h3> <p>We aimed to identify all relevant randomised controlled trials (RCTs) regardless of language or publication status (published, unpublished, in press, and in progress) </p> <section id="CD007281-sec-0047"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases up to 7 September 2012:</p> <p> <ul id="CD007281-list-0014"> <li> <p>the Cochrane Skin Group Specialised Register using the following terms: (bowen* and disease) or (bowenoid and papulosis) or (morbus and bowen) or (squamous and cell and carcinoma) or (in and situ and squamous and cell and carcinoma) or (intraepidermal and squamous and cell and carcinoma); </p> </li> <li> <p>the Cochrane Central Register of Controlled Trials (CENTRAL), 2012, Issue 9, in <i>The Cochrane Library</i> using the search strategy in <a href="./appendices#CD007281-sec-0181">Appendix 1</a>; </p> </li> <li> <p>MEDLINE via OVID (from 1946) using the strategy in <a href="./appendices#CD007281-sec-0182">Appendix 2</a>; </p> </li> <li> <p>EMBASE via OVID (from 1974) using the strategy in <a href="./appendices#CD007281-sec-0183">Appendix 3</a>; </p> </li> <li> <p>LILACS (Latin American and Caribbean Health Science Information database, from 1982) using the strategy in <a href="./appendices#CD007281-sec-0184">Appendix 4</a>; and </p> </li> <li> <p>PsycINFO via OVID (from 1806) using the terms 'random.mp.' and 'squamous cell carcinoma.mp'.</p> </li> </ul> </p> <section id="CD007281-sec-0048"> <h5 class="title">Trials registers</h5> <p>We searched the following trials registers on 15 February 2012 using the following terms: (bowen* and disease) or (morbus and bowen) or (squamous and cell and carcinoma) or (in and situ and squamous and cell and carcinoma) or (intraepidermal and squamous and cell and carcinoma). </p> <p> <ul id="CD007281-list-0015"> <li> <p>The metaRegister of Controlled Trials (<a href="http://www.controlled-trials.com" target="_blank">www.controlled‐trials.com</a>). </p> </li> <li> <p>The US National Institutes of Health Ongoing Trials Register (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>). </p> </li> <li> <p>The Australian New Zealand Clinical Trials Registry (<a href="http://www.anzctr.org.au" target="_blank">www.anzctr.org.au</a>). </p> </li> <li> <p>The World Health Organization International Clinical Trials Registry platform (<a href="http://www.who.int/trialsearch" target="_blank">www.who.int/trialsearch</a>). </p> </li> <li> <p>The Ongoing Skin Trials Register (<a href="http://skin.cochrane.org/ongoing-skin-trials-register" target="_blank">http://skin.cochrane.org/ongoing‐skin‐trials‐register</a>). </p> </li> </ul> </p> <p>Details of the trials found are in the '<a href="./references#CD007281-sec-0197" title="">Characteristics of ongoing studies</a>' tables. </p> </section> </section> <section id="CD007281-sec-0049"> <h4 class="title">Searching other resources</h4> <section id="CD007281-sec-0050"> <h5 class="title">Reference lists</h5> <p>We checked the bibliographies of included and excluded studies and published reviews for further references to relevant trials. </p> </section> <section id="CD007281-sec-0051"> <h5 class="title">Correspondence</h5> <p>The authors did not contact any pharmaceutical companies.</p> </section> <section id="CD007281-sec-0052"> <h5 class="title">Adverse events</h5> <p>We did not perform a separate search for adverse effects of interventions used for the treatment of Bowen's disease. We considered adverse and side‐effects described in included studies only. </p> </section> </section> </section> <section id="CD007281-sec-0053"> <h3 class="title" id="CD007281-sec-0053">Data collection and analysis</h3> <section id="CD007281-sec-0054"> <h4 class="title">Selection of studies</h4> <p>Two authors (FB‐H and RM) reviewed the titles and abstracts identified from the searches. We did not seek the full text of studies that were clearly not randomised controlled trials of treatments for Bowen's disease. The same two authors independently assessed the full text version of the remaining studies against the predefined selection criteria. We resolved differences of opinion through discussion with a third author (JL‐B). </p> </section> <section id="CD007281-sec-0055"> <h4 class="title">Data extraction and management</h4> <p>Two authors (JL‐B and RM) independently extracted the data using a specially designed data extraction form. The third author (FB‐H) resolved any differences of opinion. Two authors entered data into Review Manager (FB‐H and RM). </p> <p>Cosmetic outcome, consumer satisfaction with cosmesis, consumer pain ratings, and severity of adverse effects are all ordinal data outcomes. Where possible, we translated these outcomes into dichotomous data and reported both the original and translated results. </p> <p>All other outcomes were expressed as actual or percentage differences between treatment arms. </p> </section> <section id="CD007281-sec-0056"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>The assessment of the methodological quality of included studies included an evaluation of the following components of internal and external validity for each included study, since there is some evidence that these are associated with biased estimates of treatment effect (<a href="./references#CD007281-bbs2-0036" title="JuniP , AltmanDG , EggerM . Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ2001;323(7303):42‐6. [MEDLINE: 11440947] ">Juni 2001</a>):<br/> (a) the method of generation of the randomisation sequence;<br/> (b) the method of allocation concealment ‐ we considered it 'adequate' if the assignment could not be foreseen;<br/> (c) who was blinded and not blinded (participants, clinicians, outcome assessors), if appropriate;<br/> (d) the number of participants lost to follow up in each treatment arm, and if the reasons for losses were adequately reported; and<br/> (e) whether all participants were analysed according to the groups to which they were initially randomised (intention‐to‐treat principle). </p> <p>In addition, we assessed baseline comparability between treatment arms ‐ this included consideration of age, gender of participants at baseline, and size and site of treated lesion(s) of Bowen's disease. Where these features were significantly different, we highlighted this as high risk of bias. </p> </section> <section id="CD007281-sec-0057"> <h4 class="title">Measures of treatment effect</h4> <p>We expressed the results as risk ratios (RR) with 95% confidence intervals (CI) for dichotomous outcomes. </p> <p>Where we could not dichotomise ordinal data, we reported the results narratively.</p> <p>We translated ordinal outcomes (cosmetic outcome, consumer satisfaction with cosmesis, consumer pain ratings, and severity of adverse effects) into dichotomous data using established cut‐off points, where possible. </p> <p>For individual studies that had outcome data with zero event rates, we assessed whether there was a significant treatment effect by performing a Fisher's Exact test for parallel‐group studies and McNemar’s test for within‐participant studies (using an exact two‐sided P value). </p> </section> <section id="CD007281-sec-0058"> <h4 class="title">Unit of analysis issues</h4> <p>The main unit of analysis was the lesion because the studies did not present their findings by individual participants. We accepted that this will yield 95% CIs that do not take the clustering at participant level into account; thus, the estimated standard errors were less conservative, resulting in narrower 95% CIs. Therefore, any significant findings are likely to be credible. </p> <p>We analysed internally controlled trials using appropriate methods for paired designs, and we did not pool these studies with studies of other designs. Where a trial contained multiple intervention groups, we made pair‐wise comparisons of interventions versus placebo or other interventions. </p> </section> <section id="CD007281-sec-0059"> <h4 class="title">Dealing with missing data</h4> <p>We dealt with missing data due to participant dropout through intention‐to‐treat analysis. We analysed all trial participants according to the group to which they were assigned, and we included, where possible, all participants in the analysis irrespective of whether their outcomes were actually collected. For dichotomous outcomes, we assumed that all the 'missings' had a poor outcome. </p> </section> <section id="CD007281-sec-0060"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed heterogeneity or variability between studies visually, and we quantified using the I² statistic. I² statistic describes the percentage of the variability in effect estimates that is due to variability among the studies rather than chance (<a href="./references#CD007281-bbs2-0033" title="HigginsJPT , GreenS (eds) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane‐handbook.org, 2011. ">Higgins 2011</a>). Where I² statistic was &gt; 85%, we did not perform meta‐analysis. </p> </section> <section id="CD007281-sec-0061"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to use funnel plots to alert us to the potential of publication bias, although we are aware that factors other than publication bias can cause asymmetric funnel plots, and conversely, publication bias may be present with a symmetrical funnel plot. </p> </section> <section id="CD007281-sec-0062"> <h4 class="title">Data synthesis</h4> <p>If the included studies had sufficient homogeneity, we performed a meta‐analysis to calculate a weighted treatment effect across trials. The degree of heterogeneity determined if we used a fixed‐effect or random‐effects model. Where data were not available to perform a meta‐analysis, we summarised the data for each trial narratively. </p> </section> <section id="CD007281-sec-0063"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>In our protocol, we planned that if substantial heterogeneity existed (I² statistic &gt; 50%) between studies for the primary outcome, we would explore heterogeneity by examining the effects of excluding study subgroups, e.g. those studies with lower reported methodological quality (i.e. studies that did not clearly report randomisation or blinding, and which do not have an intention‐to‐treat analysis). </p> <p>We also planned to investigate potential causes of the heterogeneity, including dosage and duration of treatment, lesion characteristics (size, body site), and age groups of participants. </p> <p>We planned to conduct subgroup analyses where adequate information was available, with the groups including the following: body site of lesion (particularly lower leg lesions, i.e. located below the knee), size of lesion (particularly lesions &gt; 2 cm), age of the participants (particularly those over 70 years of age), and participants with medical comorbidities (particularly those that could affect wound healing). However, in this review, we were unable to undertake such subgroup analyses, but may be able to in future updates. </p> </section> <section id="CD007281-sec-0064"> <h4 class="title">Sensitivity analysis</h4> <p>In our protocol, we planned to conduct sensitivity analyses to assess the robustness of the results of the review, relative to the key assumptions; however, in this review, we did not undertake any sensitivity analyses. This may be possible in future updates. </p> <section id="CD007281-sec-0065"> <h5 class="title">Adverse outcomes</h5> <p>Where data were available, we gave a RR, and where this was not available, we summarised and described the information qualitatively. </p> </section> <section id="CD007281-sec-0066"> <h5 class="title">Other</h5> <p>The consumer in our team (JD) ensured the final review was relevant, readable, and understandable. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD007281-sec-0067" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD007281-sec-0067"></div> <section id="CD007281-sec-0068"> <h3 class="title">Description of studies</h3> <section id="CD007281-sec-0069"> <h4 class="title">Results of the search</h4> <p>The electronic search identified 283 references to studies. We identified six additional ongoing studies. Of the 289 records screened, we excluded 273 references based on the titles and abstracts, and we sought the full text of 16 studies. After reading the full text, we included nine studies and excluded seven studies (see <a href="#CD007281-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD007281-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD007281-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> </section> <section id="CD007281-sec-0070"> <h4 class="title">Included studies</h4> <p>We included a total of 9 studies, with 363 participants (132 men and 231 women), in the review, and we addressed the following comparisons: </p> <section id="CD007281-sec-0071"> <h5 class="title">Interventions</h5> <section id="CD007281-sec-0072"> <h6 class="title">1. Photodynamic therapy</h6> <p> <ul id="CD007281-list-0016"> <li> <p>5‐aminolevulinic acid with photodynamic therapy (ALA‐PDT) single illumination versus ALA‐PDT two‐fold illumination (<a href="./references#CD007281-bbs2-0001" title="deHaasER , SterenborgHJ , NeumannHA , RobinsonDJ . Response of Bowen disease to ALA‐PDT using a single and a 2‐fold illumination scheme. Archives of Dermatology2007;143(2):264‐5. [MEDLINE: 17310011] ">de Haas 2007</a>; <a href="./references#CD007281-bbs2-0008" title="Puizina‐IvicN , ZorcH , Vanjaka‐RogosicL , MiricL , PersinA . Fractionated illumination improves the outcome in the treatment of precanerous lesions with photodynamic therapy. Collegium Antropologicum2008;32(Suppl 2):67‐73. [MEDLINE: 19138010] ">Puizina‐Ivic 2008</a>) </p> </li> <li> <p>5‐aminolevulinic acid with photodynamic therapy (ALA‐PDT) red light versus ALA‐PDT green light (<a href="./references#CD007281-bbs2-0004" title="MortonCA , WhitehurstC , MooreJV , MacKieRM . Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. British Journal of Dermatology2000;143(4):767‐72. [MEDLINE: 11069454] ">Morton 2000</a>) </p> </li> <li> <p>Intravenous (IV) verteporfin with red light at 60 versus 120 versus 180 J/cm² (<a href="./references#CD007281-bbs2-0002" title="LuiH , BobbsL , TopeWD , LeePK , ElmetsC , ProvostN , et al. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light‐emitting diodes: two‐year results evaluating tumor response and cosmetic outcomes. Archives of Dermatology2004;140(1):26‐32. [MEDLINE: 14732656] ">Lui 2004</a>) </p> </li> <li> <p>Methyl aminolevulinate with photodynamic therapy (MAL‐PDT) versus placebo versus cryotherapy versus 5‐FU (5‐fluorouracil) (<a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>) </p> </li> </ul> </p> </section> <section id="CD007281-sec-0073"> <h6 class="title">2. Cryotherapy</h6> <p> <ul id="CD007281-list-0017"> <li> <p>Cryotherapy versus placebo versus MAL‐PDT versus 5‐FU (<a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>) </p> </li> <li> <p>Cryotherapy versus ALA‐PDT (<a href="./references#CD007281-bbs2-0003" title="MortonCA , WhitehurstC , MoseleyH , McCollJH , MooreJV , MackieRM . Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. British Journal of Dermatology1996;135(5):766‐71. [MEDLINE: 8977678] ">Morton 1996</a>) </p> </li> </ul> </p> </section> <section id="CD007281-sec-0074"> <h6 class="title">3. 5‐fluorouracil</h6> <p> <ul id="CD007281-list-0018"> <li> <p>5‐fluorouracil (5‐FU) versus placebo versus MAL‐PDT versus cryotherapy (<a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>) </p> </li> <li> <p>5‐fluorouracil versus ALA‐PDT (<a href="./references#CD007281-bbs2-0007" title="PerrettCM , McGregorJM , WarwickJ , KarranP , LeighIM , ProbyCM , et al. Treatment of post‐transplant premalignant skin disease: a randomised intrapatient comparative study of 5‐fluorouracil cream and topical photodynamic therapy. British Journal of Dermatology2007;156(2):320‐8. [MEDLINE: 17223873] ">Perrett 2007</a>; <a href="./references#CD007281-bbs2-0009" title="SalimS , LemanJA , McCollJH , ChapmanR , MortonCA . Randomised comparison of photodynamic therapy with topical 5‐fluorouracil in Bowen's disease. British Journal of Dermatology2003;148(3):539‐43. [MEDLINE: 12653747] ">Salim 2003</a>) </p> </li> </ul> </p> </section> <section id="CD007281-sec-0075"> <h6 class="title">4. Imiquimod</h6> <p> <ul id="CD007281-list-0019"> <li> <p>Imiquimod versus placebo (<a href="./references#CD007281-bbs2-0006" title="PatelGK , GoodwinR , ChawlaM , LaidlerP , PricePE , FinlayAY , et al. Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): A randomised, double‐blind placebo‐controlled trial. Journal of the American Academy of Dermatology2006;54(6):1025‐32. [MEDLINE: 16713457] ">Patel 2006</a>) </p> </li> </ul> </p> </section> </section> <section id="CD007281-sec-0076"> <h5 class="title">Design</h5> <p>Of the nine included RCTs, only one was a within‐participant study comparing PDT and 5‐FU in post‐transplant recipients (<a href="./references#CD007281-bbs2-0007" title="PerrettCM , McGregorJM , WarwickJ , KarranP , LeighIM , ProbyCM , et al. Treatment of post‐transplant premalignant skin disease: a randomised intrapatient comparative study of 5‐fluorouracil cream and topical photodynamic therapy. British Journal of Dermatology2007;156(2):320‐8. [MEDLINE: 17223873] ">Perrett 2007</a>). Two studies were placebo‐controlled; one compared imiquimod versus placebo (<a href="./references#CD007281-bbs2-0006" title="PatelGK , GoodwinR , ChawlaM , LaidlerP , PricePE , FinlayAY , et al. Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): A randomised, double‐blind placebo‐controlled trial. Journal of the American Academy of Dermatology2006;54(6):1025‐32. [MEDLINE: 16713457] ">Patel 2006</a>); and another compared MAL‐PDT to placebo‐PDT (<a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>). </p> <p>All studies randomly assigned participants or comparable lesions of participants to one of the treatment groups. </p> </section> <section id="CD007281-sec-0077"> <h5 class="title">Sample sizes</h5> <p>The number of participants evaluated in the studies varied from 8 to 225 participants. Each participant could have had up to three lesions treated. </p> </section> <section id="CD007281-sec-0078"> <h5 class="title">Setting</h5> <p>All studies were undertaken in secondary and tertiary healthcare settings.</p> <p>Five studies (<a href="./references#CD007281-bbs2-0006" title="PatelGK , GoodwinR , ChawlaM , LaidlerP , PricePE , FinlayAY , et al. Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): A randomised, double‐blind placebo‐controlled trial. Journal of the American Academy of Dermatology2006;54(6):1025‐32. [MEDLINE: 16713457] ">Patel 2006</a>; <a href="./references#CD007281-bbs2-0007" title="PerrettCM , McGregorJM , WarwickJ , KarranP , LeighIM , ProbyCM , et al. Treatment of post‐transplant premalignant skin disease: a randomised intrapatient comparative study of 5‐fluorouracil cream and topical photodynamic therapy. British Journal of Dermatology2007;156(2):320‐8. [MEDLINE: 17223873] ">Perrett 2007</a>; <a href="./references#CD007281-bbs2-0003" title="MortonCA , WhitehurstC , MoseleyH , McCollJH , MooreJV , MackieRM . Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. British Journal of Dermatology1996;135(5):766‐71. [MEDLINE: 8977678] ">Morton 1996</a>; <a href="./references#CD007281-bbs2-0004" title="MortonCA , WhitehurstC , MooreJV , MacKieRM . Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. British Journal of Dermatology2000;143(4):767‐72. [MEDLINE: 11069454] ">Morton 2000</a>; <a href="./references#CD007281-bbs2-0009" title="SalimS , LemanJA , McCollJH , ChapmanR , MortonCA . Randomised comparison of photodynamic therapy with topical 5‐fluorouracil in Bowen's disease. British Journal of Dermatology2003;148(3):539‐43. [MEDLINE: 12653747] ">Salim 2003</a>) were undertaken in the UK, and one (<a href="./references#CD007281-bbs2-0009" title="SalimS , LemanJA , McCollJH , ChapmanR , MortonCA . Randomised comparison of photodynamic therapy with topical 5‐fluorouracil in Bowen's disease. British Journal of Dermatology2003;148(3):539‐43. [MEDLINE: 12653747] ">Salim 2003</a>) was a multicentred study. One study (<a href="./references#CD007281-bbs2-0002" title="LuiH , BobbsL , TopeWD , LeePK , ElmetsC , ProvostN , et al. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light‐emitting diodes: two‐year results evaluating tumor response and cosmetic outcomes. Archives of Dermatology2004;140(1):26‐32. [MEDLINE: 14732656] ">Lui 2004</a>) was a multicentred phase II study based in four North American clinics; one was a single‐centred study from the Netherlands (<a href="./references#CD007281-bbs2-0001" title="deHaasER , SterenborgHJ , NeumannHA , RobinsonDJ . Response of Bowen disease to ALA‐PDT using a single and a 2‐fold illumination scheme. Archives of Dermatology2007;143(2):264‐5. [MEDLINE: 17310011] ">de Haas 2007</a>), and one was from Croatia (<a href="./references#CD007281-bbs2-0008" title="Puizina‐IvicN , ZorcH , Vanjaka‐RogosicL , MiricL , PersinA . Fractionated illumination improves the outcome in the treatment of precanerous lesions with photodynamic therapy. Collegium Antropologicum2008;32(Suppl 2):67‐73. [MEDLINE: 19138010] ">Puizina‐Ivic 2008</a>). One RCT was carried out across 40 dermatology clinics in 11 European countries (<a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>). </p> </section> <section id="CD007281-sec-0079"> <h5 class="title">Participants</h5> <p>Overall, there were 132 men and 231 women. The mean age of the participants was 71 years (range = 22 to 99 years). Three studies (<a href="./references#CD007281-bbs2-0002" title="LuiH , BobbsL , TopeWD , LeePK , ElmetsC , ProvostN , et al. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light‐emitting diodes: two‐year results evaluating tumor response and cosmetic outcomes. Archives of Dermatology2004;140(1):26‐32. [MEDLINE: 14732656] ">Lui 2004</a>; <a href="./references#CD007281-bbs2-0004" title="MortonCA , WhitehurstC , MooreJV , MacKieRM . Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. British Journal of Dermatology2000;143(4):767‐72. [MEDLINE: 11069454] ">Morton 2000</a>; <a href="./references#CD007281-bbs2-0008" title="Puizina‐IvicN , ZorcH , Vanjaka‐RogosicL , MiricL , PersinA . Fractionated illumination improves the outcome in the treatment of precanerous lesions with photodynamic therapy. Collegium Antropologicum2008;32(Suppl 2):67‐73. [MEDLINE: 19138010] ">Puizina‐Ivic 2008</a>) did not provide gender distribution. One study (<a href="./references#CD007281-bbs2-0008" title="Puizina‐IvicN , ZorcH , Vanjaka‐RogosicL , MiricL , PersinA . Fractionated illumination improves the outcome in the treatment of precanerous lesions with photodynamic therapy. Collegium Antropologicum2008;32(Suppl 2):67‐73. [MEDLINE: 19138010] ">Puizina‐Ivic 2008</a>) did not provide the age of the participants. </p> <p>One study (<a href="./references#CD007281-bbs2-0002" title="LuiH , BobbsL , TopeWD , LeePK , ElmetsC , ProvostN , et al. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light‐emitting diodes: two‐year results evaluating tumor response and cosmetic outcomes. Archives of Dermatology2004;140(1):26‐32. [MEDLINE: 14732656] ">Lui 2004</a>) investigating a PDT dose escalation treatment included participants with both basal cell carcinoma and Bowen's disease. One study (<a href="./references#CD007281-bbs2-0008" title="Puizina‐IvicN , ZorcH , Vanjaka‐RogosicL , MiricL , PersinA . Fractionated illumination improves the outcome in the treatment of precanerous lesions with photodynamic therapy. Collegium Antropologicum2008;32(Suppl 2):67‐73. [MEDLINE: 19138010] ">Puizina‐Ivic 2008</a>) analysed the effect of different treatment regimens with ALA‐PDT of both Bowen's disease and actinic keratoses. </p> <p>One study (<a href="./references#CD007281-bbs2-0007" title="PerrettCM , McGregorJM , WarwickJ , KarranP , LeighIM , ProbyCM , et al. Treatment of post‐transplant premalignant skin disease: a randomised intrapatient comparative study of 5‐fluorouracil cream and topical photodynamic therapy. British Journal of Dermatology2007;156(2):320‐8. [MEDLINE: 17223873] ">Perrett 2007</a>) included only post‐transplant recipients. </p> <p>Four studies (<a href="./references#CD007281-bbs2-0002" title="LuiH , BobbsL , TopeWD , LeePK , ElmetsC , ProvostN , et al. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light‐emitting diodes: two‐year results evaluating tumor response and cosmetic outcomes. Archives of Dermatology2004;140(1):26‐32. [MEDLINE: 14732656] ">Lui 2004</a>; <a href="./references#CD007281-bbs2-0004" title="MortonCA , WhitehurstC , MooreJV , MacKieRM . Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. British Journal of Dermatology2000;143(4):767‐72. [MEDLINE: 11069454] ">Morton 2000</a>; <a href="./references#CD007281-bbs2-0008" title="Puizina‐IvicN , ZorcH , Vanjaka‐RogosicL , MiricL , PersinA . Fractionated illumination improves the outcome in the treatment of precanerous lesions with photodynamic therapy. Collegium Antropologicum2008;32(Suppl 2):67‐73. [MEDLINE: 19138010] ">Puizina‐Ivic 2008</a>; <a href="./references#CD007281-bbs2-0009" title="SalimS , LemanJA , McCollJH , ChapmanR , MortonCA . Randomised comparison of photodynamic therapy with topical 5‐fluorouracil in Bowen's disease. British Journal of Dermatology2003;148(3):539‐43. [MEDLINE: 12653747] ">Salim 2003</a>) did not provide lesion size at baseline. Mean lesion size at baseline was 13.6 mm² (range = 0.23 to 50 mm²). </p> <p>We provide further details in the '<a href="./references#CD007281-sec-0195" title="">Characteristics of included studies</a>' section. </p> </section> </section> <section id="CD007281-sec-0080"> <h4 class="title">Excluded studies</h4> <p>We excluded seven studies. On reading the full text, five (<a href="./references#CD007281-bbs2-0010" title="AhmedI , Berth‐JonesJ , Charles‐HolmesS , CallaghanCJ , IlchyshynA . Comparison of cryotherapy with curettage in the treatment of Bowen's disease: a prospective study. British Journal of Dermatology2000;143(4):759‐66. [MEDLINE: 11069453] ">Ahmed 2000</a>; <a href="./references#CD007281-bbs2-0011" title="BaronED , MalbasaCL , Santo‐DomingoD , FuP , MillerJD , HannemanKK , et al. Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial. Lasers in Surgery &amp; Medicine2010;42(10):728‐35. [MEDLINE: 21246576] ">Baron 2010</a>; <a href="./references#CD007281-bbs2-0013" title="deHaasER , deVijlderHC , SterenborgHJ , NeumannHA , RobinsonDJ . Fractionated aminolevulinic acid‐photodynamic theapy provides additional evidence for the use of PDT for non‐melanoma skin cancer. Jouranal of the European Academy of Dermatology &amp; Venereology2008;22(4):426‐30. [MEDLINE: 18031503] ">de Haas 2008</a>; <a href="./references#CD007281-bbs2-0014" title="KaminakaC , YamamotoY , YoneiN , KishiokaA , KondoT , FurukawaF . Phenol peels as a novel therapeutic approach for actinic keratosis and Bowen disease: a prospective pilot trial with assessment of clinical, histologic, and immunohistochemical correlations. Journal American Academy of Dermatology2009;60(4):615‐25. [MEDLINE: 19293009] ">Kaminaka 2009</a>; <a href="./references#CD007281-bbs2-0016" title="MizutaniK , AkitaY , YanagishitaT , KimuraM , TanakaT , KinoshitaY , et al. Comparison of the efficacy of ALA‐PDT using an excimer‐dye laser (630nm) and a metal‐halide lamp (600‐740nm) for treatment of Bowen's disease. Photodermatology Photoimmunology &amp; Photomedicine2012;28(3):142‐6. [MEDLINE: 22548396] ">Mizutani 2012</a>) were not randomised controlled trials. One study (<a href="./references#CD007281-bbs2-0012" title="BrownVL , AtkinsCL , GhaliL , CerioR , HarwoodCA , ProbyCM . Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high‐risk renal transplant recipients: randomized, double‐blind, placebo‐controlled trial. Archives of Dermatology2005;141(8):985‐93. [MEDLINE: 16103328] ">Brown 2005</a>) examined dysplastic skin lesions and not specifically areas of Bowen's disease. One study (<a href="./references#CD007281-bbs2-0015" title="MacbethAE , GrindlayDJC , WilliamsHC . What's new in skin cancer? An analysis of guidelines and systematic reviews published in 2008‐2009. Clinical &amp; Experimental Dermatology2011;36(5):453‐58. [MEDLINE: 21671988] ">Macbeth 2011</a>) was an analysis of systematic reviews that did not report any RCTs of Bowen's disease. </p> <p>Please refer to the '<a href="./references#CD007281-sec-0196" title="">Characteristics of excluded studies</a>' tables for details. </p> <section id="CD007281-sec-0081"> <h5 class="title">Ongoing studies</h5> <p>We identified six studies as ongoing; please refer to the '<a href="./references#CD007281-sec-0197" title="">Characteristics of ongoing studies</a>' tables for details. </p> </section> <section id="CD007281-sec-0082"> <h5 class="title">Studies awaiting classification</h5> <p>We found no studies for this section.</p> </section> </section> </section> <section id="CD007281-sec-0083"> <h3 class="title">Risk of bias in included studies</h3> <p>We used a subjective measure of quality, classifying trials as high‐, medium‐, or low‐quality based on the four main criteria (random sequence generation, concealment of allocation, blinding of outcome assessment, and handling of withdrawals and dropouts). There was no disagreement about trial quality. In general, the methodological quality of the trials was poor. We have summarised our judgements below, and these can be seen in <a href="#CD007281-fig-0002">Figure 2</a> and <a href="#CD007281-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD007281-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study" data-id="CD007281-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study </p> </div> </div> </div> <div class="figure" id="CD007281-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies" data-id="CD007281-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies </p> </div> </div> </div> <section id="CD007281-sec-0084"> <h4 class="title">Allocation</h4> <p>In seven studies, the method of generation of the randomisation sequence was either not described or unclear. In particular, one study (<a href="./references#CD007281-bbs2-0008" title="Puizina‐IvicN , ZorcH , Vanjaka‐RogosicL , MiricL , PersinA . Fractionated illumination improves the outcome in the treatment of precanerous lesions with photodynamic therapy. Collegium Antropologicum2008;32(Suppl 2):67‐73. [MEDLINE: 19138010] ">Puizina‐Ivic 2008</a>) assigned participants to an intervention with no details of randomisation given, and another study (<a href="./references#CD007281-bbs2-0007" title="PerrettCM , McGregorJM , WarwickJ , KarranP , LeighIM , ProbyCM , et al. Treatment of post‐transplant premalignant skin disease: a randomised intrapatient comparative study of 5‐fluorouracil cream and topical photodynamic therapy. British Journal of Dermatology2007;156(2):320‐8. [MEDLINE: 17223873] ">Perrett 2007</a>) cited a textbook reference (<a href="./references#CD007281-bbs2-0042" title="Pocock , SJ . Clinical Trials: A Practical Approach. 1st Edition. Wiley‐Blackwell, 1983. ">Pocock 1983</a>) but failed to provide a clear method for randomisation. </p> <p>Two studies clearly described the randomisation: One study (<a href="./references#CD007281-bbs2-0004" title="MortonCA , WhitehurstC , MooreJV , MacKieRM . Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. British Journal of Dermatology2000;143(4):767‐72. [MEDLINE: 11069454] ">Morton 2000</a>) randomised lesions using a sealed envelope technique, and one study (<a href="./references#CD007281-bbs2-0006" title="PatelGK , GoodwinR , ChawlaM , LaidlerP , PricePE , FinlayAY , et al. Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): A randomised, double‐blind placebo‐controlled trial. Journal of the American Academy of Dermatology2006;54(6):1025‐32. [MEDLINE: 16713457] ">Patel 2006</a>) used an independent group prior to the start of the study to randomise participants to treatments; we judged these to be at low risk of bias. </p> <p>Concealment of allocation was clear in only one study (<a href="./references#CD007281-bbs2-0006" title="PatelGK , GoodwinR , ChawlaM , LaidlerP , PricePE , FinlayAY , et al. Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): A randomised, double‐blind placebo‐controlled trial. Journal of the American Academy of Dermatology2006;54(6):1025‐32. [MEDLINE: 16713457] ">Patel 2006</a>), which we judged to be at low risk of bias. We judged one study (<a href="./references#CD007281-bbs2-0002" title="LuiH , BobbsL , TopeWD , LeePK , ElmetsC , ProvostN , et al. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light‐emitting diodes: two‐year results evaluating tumor response and cosmetic outcomes. Archives of Dermatology2004;140(1):26‐32. [MEDLINE: 14732656] ">Lui 2004</a>) to be at high risk of bias and the rest as 'unclear'. </p> </section> <section id="CD007281-sec-0085"> <h4 class="title">Blinding</h4> <p>One study (<a href="./references#CD007281-bbs2-0006" title="PatelGK , GoodwinR , ChawlaM , LaidlerP , PricePE , FinlayAY , et al. Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): A randomised, double‐blind placebo‐controlled trial. Journal of the American Academy of Dermatology2006;54(6):1025‐32. [MEDLINE: 16713457] ">Patel 2006</a>) detailed blinding of participants, clinical investigators, and histopathologists, and we assessed it as at low risk of bias for these three domains. In the study by <a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>, there was evidence of partial blinding of clinicians and participants to MAL‐PDT and placebo‐PDT arms, but no blinding to the other arms of the study (cryotherapy and 5‐fluorouracil), and because of partial blinding, we classified this as unclear risk of bias for participants, clinicians, and pathologists. </p> </section> <section id="CD007281-sec-0086"> <h4 class="title">Incomplete outcome data</h4> <p>Three of the studies (<a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>; <a href="./references#CD007281-bbs2-0006" title="PatelGK , GoodwinR , ChawlaM , LaidlerP , PricePE , FinlayAY , et al. Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): A randomised, double‐blind placebo‐controlled trial. Journal of the American Academy of Dermatology2006;54(6):1025‐32. [MEDLINE: 16713457] ">Patel 2006</a>; <a href="./references#CD007281-bbs2-0009" title="SalimS , LemanJA , McCollJH , ChapmanR , MortonCA . Randomised comparison of photodynamic therapy with topical 5‐fluorouracil in Bowen's disease. British Journal of Dermatology2003;148(3):539‐43. [MEDLINE: 12653747] ">Salim 2003</a>) provided clear flowcharts detailing completeness of data, but two studies (<a href="./references#CD007281-bbs2-0002" title="LuiH , BobbsL , TopeWD , LeePK , ElmetsC , ProvostN , et al. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light‐emitting diodes: two‐year results evaluating tumor response and cosmetic outcomes. Archives of Dermatology2004;140(1):26‐32. [MEDLINE: 14732656] ">Lui 2004</a>; <a href="./references#CD007281-bbs2-0004" title="MortonCA , WhitehurstC , MooreJV , MacKieRM . Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. British Journal of Dermatology2000;143(4):767‐72. [MEDLINE: 11069454] ">Morton 2000</a>) reported this in the text. There was no loss to follow up in the other four studies (<a href="./references#CD007281-bbs2-0001" title="deHaasER , SterenborgHJ , NeumannHA , RobinsonDJ . Response of Bowen disease to ALA‐PDT using a single and a 2‐fold illumination scheme. Archives of Dermatology2007;143(2):264‐5. [MEDLINE: 17310011] ">de Haas 2007</a>; <a href="./references#CD007281-bbs2-0003" title="MortonCA , WhitehurstC , MoseleyH , McCollJH , MooreJV , MackieRM . Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. British Journal of Dermatology1996;135(5):766‐71. [MEDLINE: 8977678] ">Morton 1996</a>; <a href="./references#CD007281-bbs2-0007" title="PerrettCM , McGregorJM , WarwickJ , KarranP , LeighIM , ProbyCM , et al. Treatment of post‐transplant premalignant skin disease: a randomised intrapatient comparative study of 5‐fluorouracil cream and topical photodynamic therapy. British Journal of Dermatology2007;156(2):320‐8. [MEDLINE: 17223873] ">Perrett 2007</a>; <a href="./references#CD007281-bbs2-0008" title="Puizina‐IvicN , ZorcH , Vanjaka‐RogosicL , MiricL , PersinA . Fractionated illumination improves the outcome in the treatment of precanerous lesions with photodynamic therapy. Collegium Antropologicum2008;32(Suppl 2):67‐73. [MEDLINE: 19138010] ">Puizina‐Ivic 2008</a>). We assessed all the included studies as at low risk of bias for this domain. </p> </section> <section id="CD007281-sec-0087"> <h4 class="title">Other potential sources of bias</h4> <p>Not all studies reported baseline comparability, and in three studies (<a href="./references#CD007281-bbs2-0003" title="MortonCA , WhitehurstC , MoseleyH , McCollJH , MooreJV , MackieRM . Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. British Journal of Dermatology1996;135(5):766‐71. [MEDLINE: 8977678] ">Morton 1996</a>; <a href="./references#CD007281-bbs2-0006" title="PatelGK , GoodwinR , ChawlaM , LaidlerP , PricePE , FinlayAY , et al. Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): A randomised, double‐blind placebo‐controlled trial. Journal of the American Academy of Dermatology2006;54(6):1025‐32. [MEDLINE: 16713457] ">Patel 2006</a>; <a href="./references#CD007281-bbs2-0009" title="SalimS , LemanJA , McCollJH , ChapmanR , MortonCA . Randomised comparison of photodynamic therapy with topical 5‐fluorouracil in Bowen's disease. British Journal of Dermatology2003;148(3):539‐43. [MEDLINE: 12653747] ">Salim 2003</a>) where baseline comparability was significantly different between treatment arms, the risk of bias was high. </p> <p>Although we judged the study that only included organ transplant recipients on chronic immunosuppressive therapy (<a href="./references#CD007281-bbs2-0007" title="PerrettCM , McGregorJM , WarwickJ , KarranP , LeighIM , ProbyCM , et al. Treatment of post‐transplant premalignant skin disease: a randomised intrapatient comparative study of 5‐fluorouracil cream and topical photodynamic therapy. British Journal of Dermatology2007;156(2):320‐8. [MEDLINE: 17223873] ">Perrett 2007</a>) as at low risk of bias for baseline comparability, its results are of limited use to the immunocompetent population. </p> </section> </section> <section id="CD007281-sec-0088"> <h3 class="title" id="CD007281-sec-0088">Effects of interventions</h3> <p>For our primary outcome 'Complete clearance of the lesion', we planned that ideally clearance of the lesion would be determined by histology, but clinical clearance at follow‐up was also accepted. Since a number of treatments require more than 1 cycle of therapy, we looked at 'Number of lesions or participants cleared after first treatment cycle' and 'Recurrence at 12 months'. </p> <p>For our secondary outcomes, we had planned how we would assess some of these: We planned to assess cosmetic outcome using a recognised and validated instrument to measure cosmesis; we expected to assess consumer satisfaction that had been recorded on a Likert or Likert‐like scale; we planned to determine 'Time to complete healing of lesion following treatment' by clinical examination or by participant assessment through a diary or similar mechanism; we planned to determine 'quality of life' by any validated quality of life instrument; we planned to categorise adverse outcomes into four levels of severity and to determine the outcome of 'Recurrence of Bowen's disease in the same site' by clinical examination. However, we did not have the data with which to carry out these plans. </p> <p>We planned to assess our prespecified outcomes in relation to any interventions for the treatment of Bowen's disease (see <a href="#CD007281-sec-0042">Types of interventions</a>). However, we did not find RCTs that examined all of these interventions, so we have reported them below in the following order: </p> <p> <ul id="CD007281-list-0020"> <li> <p>Photodynamic therapy</p> </li> </ul> <ul class="plain" id="CD007281-list-0021"> <li> <ul id="CD007281-list-0022"> <li> <p>5‐aminolevulinic acid with photodynamic therapy (ALA‐PDT) single illumination versus ALA‐PDT 2‐fold illumination </p> </li> <li> <p>5‐aminolevulinic acid with photodynamic therapy (ALA‐PDT) red light versus ALA‐PDT green light </p> </li> <li> <p>Intravenous verteporfin red light</p> </li> <li> <p>Methyl aminolevulinate cream with photodynamic therapy (MAL‐PDT) versus placebo cream‐PDT</p> </li> <li> <p>Photodynamic therapy versus cryotherapy</p> </li> <li> <p>Photodynamic therapy versus 5‐fluorouracil</p> </li> </ul> </li> </ul> <ul id="CD007281-list-0023"> <li> <p>Cryotherapy versus 5‐fluorouracil</p> </li> <li> <p>Imiquimod</p> </li> </ul> </p> <section id="CD007281-sec-0089"> <h4 class="title">Photodynamic therapy (PDT)</h4> <p>We found seven studies. Two studies (<a href="./references#CD007281-bbs2-0001" title="deHaasER , SterenborgHJ , NeumannHA , RobinsonDJ . Response of Bowen disease to ALA‐PDT using a single and a 2‐fold illumination scheme. Archives of Dermatology2007;143(2):264‐5. [MEDLINE: 17310011] ">de Haas 2007</a>; <a href="./references#CD007281-bbs2-0008" title="Puizina‐IvicN , ZorcH , Vanjaka‐RogosicL , MiricL , PersinA . Fractionated illumination improves the outcome in the treatment of precanerous lesions with photodynamic therapy. Collegium Antropologicum2008;32(Suppl 2):67‐73. [MEDLINE: 19138010] ">Puizina‐Ivic 2008</a>) reported single illumination versus two‐fold illumination. The third study (<a href="./references#CD007281-bbs2-0004" title="MortonCA , WhitehurstC , MooreJV , MacKieRM . Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. British Journal of Dermatology2000;143(4):767‐72. [MEDLINE: 11069454] ">Morton 2000</a>) reported red light versus green light, and the fourth study (<a href="./references#CD007281-bbs2-0002" title="LuiH , BobbsL , TopeWD , LeePK , ElmetsC , ProvostN , et al. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light‐emitting diodes: two‐year results evaluating tumor response and cosmetic outcomes. Archives of Dermatology2004;140(1):26‐32. [MEDLINE: 14732656] ">Lui 2004</a>) examined intravenous verteporfin with red light 60 J/cm² versus 120 J/cm² versus 180 J/cm². One study (<a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>) compared photodynamic therapy to placebo; two studies (<a href="./references#CD007281-bbs2-0003" title="MortonCA , WhitehurstC , MoseleyH , McCollJH , MooreJV , MackieRM . Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. British Journal of Dermatology1996;135(5):766‐71. [MEDLINE: 8977678] ">Morton 1996</a>; <a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>) compared photodynamic therapy to cryotherapy; and three studies (<a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>; <a href="./references#CD007281-bbs2-0007" title="PerrettCM , McGregorJM , WarwickJ , KarranP , LeighIM , ProbyCM , et al. Treatment of post‐transplant premalignant skin disease: a randomised intrapatient comparative study of 5‐fluorouracil cream and topical photodynamic therapy. British Journal of Dermatology2007;156(2):320‐8. [MEDLINE: 17223873] ">Perrett 2007</a>; <a href="./references#CD007281-bbs2-0009" title="SalimS , LemanJA , McCollJH , ChapmanR , MortonCA . Randomised comparison of photodynamic therapy with topical 5‐fluorouracil in Bowen's disease. British Journal of Dermatology2003;148(3):539‐43. [MEDLINE: 12653747] ">Salim 2003</a>) compared photodynamic therapy to 5‐FU. </p> <section id="CD007281-sec-0090"> <h5 class="title">ALA‐PDT single illumination versus ALA‐PDT two‐fold illumination</h5> <p>Two studies (<a href="./references#CD007281-bbs2-0001" title="deHaasER , SterenborgHJ , NeumannHA , RobinsonDJ . Response of Bowen disease to ALA‐PDT using a single and a 2‐fold illumination scheme. Archives of Dermatology2007;143(2):264‐5. [MEDLINE: 17310011] ">de Haas 2007</a>; <a href="./references#CD007281-bbs2-0008" title="Puizina‐IvicN , ZorcH , Vanjaka‐RogosicL , MiricL , PersinA . Fractionated illumination improves the outcome in the treatment of precanerous lesions with photodynamic therapy. Collegium Antropologicum2008;32(Suppl 2):67‐73. [MEDLINE: 19138010] ">Puizina‐Ivic 2008</a>) compared ALA‐PDT single illumination to ALA‐PDT two‐fold illumination (separated by a two‐hour time interval). The methodology was different in the 2 studies, with 1 using ALA‐PDT single illumination at a dose of 75 J/cm² versus 2‐fold illumination at a dose of 20 + 80 J/cm² (<a href="./references#CD007281-bbs2-0001" title="deHaasER , SterenborgHJ , NeumannHA , RobinsonDJ . Response of Bowen disease to ALA‐PDT using a single and a 2‐fold illumination scheme. Archives of Dermatology2007;143(2):264‐5. [MEDLINE: 17310011] ">de Haas 2007</a>) and the other study (<a href="./references#CD007281-bbs2-0008" title="Puizina‐IvicN , ZorcH , Vanjaka‐RogosicL , MiricL , PersinA . Fractionated illumination improves the outcome in the treatment of precanerous lesions with photodynamic therapy. Collegium Antropologicum2008;32(Suppl 2):67‐73. [MEDLINE: 19138010] ">Puizina‐Ivic 2008</a>) using ALA‐PDT single illumination at a higher dose of 100 J/cm² versus 2‐fold illumination at the equivalent dose of 50 + 50 J/cm². The primary outcome was measured by assessing residual tumour tissue using fluorescence intensity in one study, which is not an investigation that is routinely available in dermatology clinics. Histology was also used to confirm tumour failure (<a href="./references#CD007281-bbs2-0008" title="Puizina‐IvicN , ZorcH , Vanjaka‐RogosicL , MiricL , PersinA . Fractionated illumination improves the outcome in the treatment of precanerous lesions with photodynamic therapy. Collegium Antropologicum2008;32(Suppl 2):67‐73. [MEDLINE: 19138010] ">Puizina‐Ivic 2008</a>). </p> <section id="CD007281-sec-0091"> <h6 class="title">Primary outcomes</h6> <section id="CD007281-sec-0092"> <p><b>Number of lesions that cleared after the first treatment cycle</b></p> <p>There was no statistically significant difference in the number of lesions that achieved clearance after the first treatment cycle (RR 0.81, 95% CI 0.62 to 1.06; 2 studies: <a href="./references#CD007281-bbs2-0001" title="deHaasER , SterenborgHJ , NeumannHA , RobinsonDJ . Response of Bowen disease to ALA‐PDT using a single and a 2‐fold illumination scheme. Archives of Dermatology2007;143(2):264‐5. [MEDLINE: 17310011] ">de Haas 2007</a>; <a href="./references#CD007281-bbs2-0008" title="Puizina‐IvicN , ZorcH , Vanjaka‐RogosicL , MiricL , PersinA . Fractionated illumination improves the outcome in the treatment of precanerous lesions with photodynamic therapy. Collegium Antropologicum2008;32(Suppl 2):67‐73. [MEDLINE: 19138010] ">Puizina‐Ivic 2008</a>) (<a href="./references#CD007281-fig-0004" title="">Analysis 1.1</a>). </p> </section> <section id="CD007281-sec-0093"> <p><b>Recurrence at 12 months</b></p> <p>There were no data for this outcome.</p> </section> </section> <section id="CD007281-sec-0094"> <h6 class="title">Secondary outcomes</h6> <section id="CD007281-sec-0095"> <p><b>Number of lesions that cleared after each treatment cycle/Number of treatment cycles needed to achieve clearance</b></p> <p>Only one treatment cycle was given for each intervention, so we could not determine these outcomes. </p> </section> <section id="CD007281-sec-0096"> <p><b>Recurrence at &gt; 12 months</b></p> <p>There were no data for this outcome.</p> </section> <section id="CD007281-sec-0097"> <p><b>Cosmetic outcome</b></p> <p>There was no statistically significant difference in good cosmetic outcome (RR 1.09, 95% CI 0.94 to 1.24; 1 study) (<a href="./references#CD007281-fig-0005" title="">Analysis 1.2</a>). </p> </section> <section id="CD007281-sec-0098"> <p><b>Consumer satisfaction with treatment modality, cosmesis, or pain at site</b></p> <p>There was no statistically significant difference in reporting of pain during treatment (RR 0.11, 95% CI 0.01 to 1.96; 1 study) (<a href="./references#CD007281-fig-0006" title="">Analysis 1.3</a>). </p> </section> <section id="CD007281-sec-0099"> <p><b>Time to complete healing of lesion following treatment</b></p> <p>One study (<a href="./references#CD007281-bbs2-0001" title="deHaasER , SterenborgHJ , NeumannHA , RobinsonDJ . Response of Bowen disease to ALA‐PDT using a single and a 2‐fold illumination scheme. Archives of Dermatology2007;143(2):264‐5. [MEDLINE: 17310011] ">de Haas 2007</a>) reported a three‐week maximum healing time, which was not different between intervention groups, although actual times were not provided. </p> </section> <section id="CD007281-sec-0100"> <p><b>Adverse outcomes</b></p> <p>One study (<a href="./references#CD007281-bbs2-0001" title="deHaasER , SterenborgHJ , NeumannHA , RobinsonDJ . Response of Bowen disease to ALA‐PDT using a single and a 2‐fold illumination scheme. Archives of Dermatology2007;143(2):264‐5. [MEDLINE: 17310011] ">de Haas 2007</a>) provided data for adverse events and reported no serious adverse events, with the exception of a non‐statistically significant difference in reporting of pain (RR 0.11, 95% CI 0.01 to 1.96) (<a href="./references#CD007281-fig-0006" title="">Analysis 1.3</a>). </p> </section> <section id="CD007281-sec-0101"> <p><b>Quality of life</b></p> </section> <section id="CD007281-sec-0102"> <p><b>Recurrence of Bowen's disease in the same site</b></p> <p>There were no data for these outcomes.</p> </section> </section> </section> <section id="CD007281-sec-0103"> <h5 class="title">ALA‐PDT red light versus ALA‐PDT green light</h5> <p>One study (<a href="./references#CD007281-bbs2-0004" title="MortonCA , WhitehurstC , MooreJV , MacKieRM . Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. British Journal of Dermatology2000;143(4):767‐72. [MEDLINE: 11069454] ">Morton 2000</a>) compared ALA‐PDT red light versus ALA‐PDT green light. </p> <section id="CD007281-sec-0104"> <h6 class="title">Primary outcomes</h6> <section id="CD007281-sec-0105"> <p><b>Number of lesions that cleared after the first treatment cycle.</b></p> <p>There was no significant difference in the number of lesions that cleared after the first cycle (RR 1.21, 95% CI 0.85 to 1.71; 1 study) (<a href="./references#CD007281-fig-0007" title="">Analysis 2.1</a>). </p> </section> <section id="CD007281-sec-0106"> <p><b>Recurrence at 12 months</b></p> <p>There were 74% fewer recurrences in the red light group (2/32) compared to the green light group (7/29) (RR 0.26, 95% CI 0.06 to 1.15; 1 study) (<a href="./references#CD007281-fig-0008" title="">Analysis 2.2</a>). </p> </section> </section> <section id="CD007281-sec-0107"> <h6 class="title">Secondary outcomes</h6> <section id="CD007281-sec-0108"> <p><b>Number of lesions that cleared after each treatment cycle</b></p> <p>A significantly greater proportion of lesions cleared after the second cycle of treatment with red light compared with treatment with green light (RR 1.29, 95% CI 1.02 to 1.65; 1 study; n = 61) (<a href="./references#CD007281-fig-0009" title="">Analysis 2.3</a>). </p> </section> <section id="CD007281-sec-0109"> <p><b>Number of treatment cycles needed to achieve clearance</b></p> <p>Two treatment cycles were used in 9 participants who failed to respond to 1 treatment cycle. </p> </section> <section id="CD007281-sec-0110"> <p><b>Recurrence at &gt; 12 months</b></p> <p>There were no data available beyond 12 months.</p> </section> <section id="CD007281-sec-0111"> <p><b>Cosmetic outcome</b></p> <p>No clinically‐obvious scars were present in either group at 12 months.</p> </section> <section id="CD007281-sec-0112"> <p><b>Adverse outcomes</b></p> <p>There was no significant difference in the only adverse effect reported, which was perceived pain, between ALA‐PDT red light and ALA‐PDT green light treatment groups (RR 1.09, 95% CI 0.79 to 1.49; 1 study) (<a href="./references#CD007281-fig-0010" title="">Analysis 2.4</a>). </p> <p>With regard to the other secondary outcomes, there were no data for these.</p> </section> </section> </section> <section id="CD007281-sec-0113"> <h5 class="title">Intravenous (IV) verteporfin red light</h5> <p>One study (<a href="./references#CD007281-bbs2-0002" title="LuiH , BobbsL , TopeWD , LeePK , ElmetsC , ProvostN , et al. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light‐emitting diodes: two‐year results evaluating tumor response and cosmetic outcomes. Archives of Dermatology2004;140(1):26‐32. [MEDLINE: 14732656] ">Lui 2004</a>) compared IV verteporfin with red light at 3 different doses (60 J/cm² versus 120 J/cm² versus 180 J/cm²). In this study, only 34 of 421 participants had Bowen's disease, and these participants were included in the analysis. </p> <section id="CD007281-sec-0114"> <h6 class="title">Primary outcomes</h6> <section id="CD007281-sec-0115"> <p><b>Number of lesions cleared after the first treatment cycle</b></p> <p>There was no statistically significant difference in the proportion of lesions that cleared after the first treatment cycle when IV verteporfin and red light at a dose of 60 J/cm² was compared to 120 J/cm² (RR 0.98, 95% CI 0.43 to 2.24; 1 study) (<a href="./references#CD007281-fig-0011" title="">Analysis 3.1</a>), or a dose of 60 J/cm² was compared to a dose of 180 J/cm² (RR 1.48, 95% CI 0.81 to 2.72; 1 study) (<a href="./references#CD007281-fig-0012" title="">Analysis 3.2</a>), or a dose of 120 J/cm² was compared to 180 J/cm² (RR 1.50, 95% CI 0.57 to 3.95) (<a href="./references#CD007281-fig-0013" title="">Analysis 3.3</a>). </p> </section> <section id="CD007281-sec-0116"> <p><b>Recurrence at 12 months</b></p> <p>Data stratified according to tumour type were not provided.</p> </section> </section> <section id="CD007281-sec-0117"> <h6 class="title">Secondary outcomes</h6> <section id="CD007281-sec-0118"> <p><b>Number of lesions that cleared after each treatment cycle/Number of treatment cycles needed to achieve clearance</b></p> <p>A second cycle of treatment was given in some cases although these data were not given.</p> <p>No data were given for the other secondary outcomes: recurrence at &gt; 12 months; cosmetic outcome; consumer satisfaction with treatment modality, cosmesis, or pain; time to complete healing of lesion following treatment; quality of life, or recurrence of Bowen's disease in the same site. No separate data on adverse outcomes was provided for lesions of Bowen's disease. </p> </section> </section> </section> <section id="CD007281-sec-0119"> <h5 class="title">MAL‐PDT versus placebo</h5> <p>One study (<a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>) compared MAL‐PDT (methyl aminolevulinate cream with photodynamic therapy) versus placebo cream‐PDT. </p> <section id="CD007281-sec-0120"> <h6 class="title">Primary outcomes</h6> <section id="CD007281-sec-0121"> <p><b>Number of lesions that cleared after the first treatment cycle</b></p> <p>There were a statistically significantly greater proportion of lesions cleared with MAL‐PDT compared to placebo (RR 1.68, 95% CI 1.12 to 2.52; 1 study, n = 148) (<a href="./references#CD007281-fig-0014" title="">Analysis 4.1</a>). </p> </section> <section id="CD007281-sec-0122"> <p><b>Recurrence at 12 months</b></p> <p>There were statistically significantly fewer recurrences of lesions in the MAL‐PDT group compared with placebo (RR 0.29, 95% CI 0.10 to 0.86; 1 study, n = 107) (<a href="./references#CD007281-fig-0015" title="">Analysis 4.2</a>). </p> </section> </section> <section id="CD007281-sec-0123"> <h6 class="title">Secondary outcomes</h6> <section id="CD007281-sec-0124"> <p><b>Number of lesions that cleared after each treatment cycle</b></p> <p>There was no statistically significant difference in the number of lesions cleared after 2 treatment cycles (RR 1.00, 95% CI 0.94 to 1.06) (<a href="./references#CD007281-fig-0016" title="">Analysis 4.3</a>). </p> </section> <section id="CD007281-sec-0125"> <p><b>Number of treatment cycles needed to achieve clearance</b></p> <p>In all cases, two treatment cycles were used to achieve clearance.</p> </section> <section id="CD007281-sec-0126"> <p><b>Consumer satisfaction with treatment modality, cosmesis, or pain at site</b></p> <p>There was no significant difference in the number of participants reporting pain (RR 0.82, 95% CI 0.37 to 1.85; 1 study) (<a href="./references#CD007281-fig-0017" title="">Analysis 4.4</a>). </p> </section> <section id="CD007281-sec-0127"> <p><b>Adverse events</b></p> <p>There was no significant difference in the number of participants reporting more than 1 adverse event between the MAL‐PDT and placebo‐PDT groups (RR 1.06, 95% CI 0.69 to 1.63; 1 study) (<a href="./references#CD007281-fig-0018" title="">Analysis 4.5</a>). </p> <p>There were three serious adverse events in the MAL‐PDT group, but these were deemed unrelated to the intervention. Overall, 48/96 participants treated with MAL‐PDT reported greater than 1 of the following local adverse events: pain (19/96), erythema (8/96), burning sensation (16/96), crusting (8/96), stinging (9/96), irritation (3/96), itching (1/96), oedema (2/96), hyperpigmentation (3/96), or warmth (3/96) (<a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>). </p> <p>With regard to the other secondary outcomes, no data were given for these.</p> </section> </section> </section> <section id="CD007281-sec-0128"> <h5 class="title">Photodynamic therapy versus cryotherapy</h5> <p>Two studies compared PDT to cryotherapy: MAL‐PDT (<a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>) and ALA‐PDT (<a href="./references#CD007281-bbs2-0003" title="MortonCA , WhitehurstC , MoseleyH , McCollJH , MooreJV , MackieRM . Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. British Journal of Dermatology1996;135(5):766‐71. [MEDLINE: 8977678] ">Morton 1996</a>). </p> <section id="CD007281-sec-0129"> <h6 class="title">Primary outcomes</h6> <section id="CD007281-sec-0130"> <p><b>Number of lesions that cleared after the first treatment cycle</b></p> <p>A significantly greater proportion of lesions cleared with MAL‐PDT compared to cryotherapy (RR 1.17, 95% CI 1.01 to 1.37; n = 215; <a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>) (<a href="./references#CD007281-fig-0019" title="">Analysis 5.1</a>). There was no significant difference in the number of lesions that cleared when ALA‐PDT was compared to cryotherapy (RR 1.50, 95% CI 0.90 to 2.49; <a href="./references#CD007281-bbs2-0003" title="MortonCA , WhitehurstC , MoseleyH , McCollJH , MooreJV , MackieRM . Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. British Journal of Dermatology1996;135(5):766‐71. [MEDLINE: 8977678] ">Morton 1996</a>) (<a href="./references#CD007281-fig-0019" title="">Analysis 5.1</a>). </p> </section> <section id="CD007281-sec-0131"> <p><b>Recurrence at 12 months</b></p> <p>There was no statistically significant difference in recurrence at 12 months for either MAL‐PDT versus cryotherapy (RR 0.71, 95% CI 0.37 to 1.36) (<a href="./references#CD007281-fig-0020" title="">Analysis 5.2</a>) or ALA‐PDT versus cryotherapy (0/20 in the first group and 2/20 in the second group (Fisher's Exact P value = 0.49)). </p> </section> </section> <section id="CD007281-sec-0132"> <h6 class="title">Secondary outcomes</h6> <section id="CD007281-sec-0133"> <p><b>Number of lesions that cleared after each treatment cycle</b></p> <p>There was no statistically significant difference in the number of lesions that cleared in the ALA‐PDT group compared to cryotherapy after the second treatment cycle (RR 1.24, 95% CI 0.98 to 1.57; <a href="./references#CD007281-bbs2-0003" title="MortonCA , WhitehurstC , MoseleyH , McCollJH , MooreJV , MackieRM . Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. British Journal of Dermatology1996;135(5):766‐71. [MEDLINE: 8977678] ">Morton 1996</a>) (<a href="./references#CD007281-fig-0021" title="">Analysis 5.3</a>). </p> <p>There was no statistically significant difference in the number of lesions that cleared in the MAL‐PDT group compared to cryotherapy (RR 1.00, 95% CI 0.98 to 1.02; <a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>) (<a href="./references#CD007281-fig-0021" title="">Analysis 5.3</a>). </p> </section> <section id="CD007281-sec-0134"> <p><b>Cosmetic outcome</b></p> <p>At a final review at 12 months following clearance, a visible scar in the treatment field was observed in 4 lesions treated by cryotherapy, while visible scarring was absent in all lesions treated by ALA‐PDT (<a href="./references#CD007281-bbs2-0003" title="MortonCA , WhitehurstC , MoseleyH , McCollJH , MooreJV , MackieRM . Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. British Journal of Dermatology1996;135(5):766‐71. [MEDLINE: 8977678] ">Morton 1996</a>). </p> <p>Cosmetic appearance at 12 months was statistically significantly better in the MAL‐PDT group compared to cryotherapy (RR 1.59, 95% CI 1.30 to 1.93; n = 147; <a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>) (<a href="./references#CD007281-fig-0022" title="">Analysis 5.4</a>). </p> </section> <section id="CD007281-sec-0135"> <p><b>Adverse outcomes</b></p> <p>Statistically significantly fewer participants reported pain in the ALA‐PDT group compared to cryotherapy (RR 0.58, 95% CI 0.38 to 0.87, n = 40; <a href="./references#CD007281-bbs2-0003" title="MortonCA , WhitehurstC , MoseleyH , McCollJH , MooreJV , MackieRM . Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. British Journal of Dermatology1996;135(5):766‐71. [MEDLINE: 8977678] ">Morton 1996</a>) (<a href="./references#CD007281-fig-0023" title="">Analysis 5.5</a>). There was no significant difference in reported pain when MAL‐PDT was compared to cryotherapy (RR 0.81, 95% CI 0.47 to 1.41; <a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>) (<a href="./references#CD007281-fig-0023" title="">Analysis 5.5</a>). </p> <p>There was no statistically significant difference in the number of adverse events (&gt; = 1) when MAL‐PDT was compared to cryotherapy (RR 1.07, 95% CI 0.84 to 1.36; <a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>) (<a href="./references#CD007281-fig-0024" title="">Analysis 5.6</a>). </p> <p><a href="./references#CD007281-bbs2-0003" title="MortonCA , WhitehurstC , MoseleyH , McCollJH , MooreJV , MackieRM . Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. British Journal of Dermatology1996;135(5):766‐71. [MEDLINE: 8977678] ">Morton 1996</a> reported ulceration at the site of cryotherapy in 5/20 lesions, with 2/5 lesions subsequently requiring treatment with systemic antibiotics. </p> <p>With regard to the other secondary outcomes, no data were given for these.</p> </section> </section> </section> <section id="CD007281-sec-0136"> <h5 class="title">Photodynamic therapy versus 5‐fluorouracil</h5> <p>Three studies (<a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>; <a href="./references#CD007281-bbs2-0007" title="PerrettCM , McGregorJM , WarwickJ , KarranP , LeighIM , ProbyCM , et al. Treatment of post‐transplant premalignant skin disease: a randomised intrapatient comparative study of 5‐fluorouracil cream and topical photodynamic therapy. British Journal of Dermatology2007;156(2):320‐8. [MEDLINE: 17223873] ">Perrett 2007</a>; <a href="./references#CD007281-bbs2-0009" title="SalimS , LemanJA , McCollJH , ChapmanR , MortonCA . Randomised comparison of photodynamic therapy with topical 5‐fluorouracil in Bowen's disease. British Journal of Dermatology2003;148(3):539‐43. [MEDLINE: 12653747] ">Salim 2003</a>) compared PDT versus 5‐FU (5‐fluorouracil). One study (<a href="./references#CD007281-bbs2-0007" title="PerrettCM , McGregorJM , WarwickJ , KarranP , LeighIM , ProbyCM , et al. Treatment of post‐transplant premalignant skin disease: a randomised intrapatient comparative study of 5‐fluorouracil cream and topical photodynamic therapy. British Journal of Dermatology2007;156(2):320‐8. [MEDLINE: 17223873] ">Perrett 2007</a>) was an intrapatient comparison undertaken in organ‐transplant recipients, which compared MAL‐PDT (75 J/cm²) to 5‐FU. One study (<a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>) compared MAL‐PDT (dose 75 J/cm² given x 2 treatment cycles) to 5‐FU. One study (<a href="./references#CD007281-bbs2-0009" title="SalimS , LemanJA , McCollJH , ChapmanR , MortonCA . Randomised comparison of photodynamic therapy with topical 5‐fluorouracil in Bowen's disease. British Journal of Dermatology2003;148(3):539‐43. [MEDLINE: 12653747] ">Salim 2003</a>) compared ALA‐PDT (100 J/cm²) to 5‐FU. </p> <section id="CD007281-sec-0137"> <h6 class="title">Primary outcomes</h6> <section id="CD007281-sec-0138"> <p><b>Number of lesions that cleared after the first treatment cycle</b></p> <p>There was no statistically significant difference in number of lesions that cleared when MAL‐PDT was compared to 5‐FU (RR 1.16, 95% CI 0.93 to 1.44; <a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>) (<a href="./references#CD007281-fig-0025" title="">Analysis 6.1</a>). </p> <p>When ALA‐PDT was compared to 5‐FU, a significantly greater proportion of lesions were cleared in the ALA‐PDT group compared to treatment with 5‐FU (RR 1.83, 95% CI 1.10 to 3.06; n = 66; <a href="./references#CD007281-bbs2-0009" title="SalimS , LemanJA , McCollJH , ChapmanR , MortonCA . Randomised comparison of photodynamic therapy with topical 5‐fluorouracil in Bowen's disease. British Journal of Dermatology2003;148(3):539‐43. [MEDLINE: 12653747] ">Salim 2003</a>) (<a href="./references#CD007281-fig-0025" title="">Analysis 6.1</a>). </p> <p>The study that included an immunosuppressed population found no significant difference in the number of lesions that cleared when MAL‐PDT was compared with 5‐FU (McNemar's test ‐ P value = 0.125 (2‐sided exact P value)) (RR 9.00, 95% CI 0.61 to 133.08; <a href="./references#CD007281-bbs2-0007" title="PerrettCM , McGregorJM , WarwickJ , KarranP , LeighIM , ProbyCM , et al. Treatment of post‐transplant premalignant skin disease: a randomised intrapatient comparative study of 5‐fluorouracil cream and topical photodynamic therapy. British Journal of Dermatology2007;156(2):320‐8. [MEDLINE: 17223873] ">Perrett 2007</a>) (<a href="./references#CD007281-fig-0025" title="">Analysis 6.1</a>). </p> </section> <section id="CD007281-sec-0139"> <p><b>Recurrence at &gt; 12 months</b></p> <p>There were no statistically significant differences in recurrence at 12 months or greater when either MAL‐PDT (RR 1.09, 95% CI 0.39 to 3.08; <a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>) or ALA‐PDT (RR 0.33, 95% CI 0.07 to 1.53; <a href="./references#CD007281-bbs2-0009" title="SalimS , LemanJA , McCollJH , ChapmanR , MortonCA . Randomised comparison of photodynamic therapy with topical 5‐fluorouracil in Bowen's disease. British Journal of Dermatology2003;148(3):539‐43. [MEDLINE: 12653747] ">Salim 2003</a>) was compared to 5‐FU (<a href="./references#CD007281-fig-0026" title="">Analysis 6.2</a>). </p> </section> </section> <section id="CD007281-sec-0140"> <h6 class="title">Secondary outcomes</h6> <section id="CD007281-sec-0141"> <p><b>Number of lesions that cleared after each treatment cycle</b></p> <p>All lesions were cleared after the second treatment cycle in both treatment groups when MAL‐PDT was compared to 5‐FU (RR 1.00, 95% CI 0.96 to 1.04; <a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>) (<a href="./references#CD007281-fig-0027" title="">Analysis 6.3</a>). </p> <p>After the second treatment cycle when ALA‐PDT was compared to 5‐FU, statistically significantly more lesions cleared in the ALA‐PDT group compared to 5‐FU (RR 1.32, 95% CI 1.0 to 1.73; n = 66; <a href="./references#CD007281-bbs2-0009" title="SalimS , LemanJA , McCollJH , ChapmanR , MortonCA . Randomised comparison of photodynamic therapy with topical 5‐fluorouracil in Bowen's disease. British Journal of Dermatology2003;148(3):539‐43. [MEDLINE: 12653747] ">Salim 2003</a>) (<a href="./references#CD007281-fig-0027" title="">Analysis 6.3</a>). </p> </section> <section id="CD007281-sec-0142"> <p><b>Cosmetic outcome</b></p> <p>Cosmetic outcome was statistically significantly better in the MAL‐PDT group compared to 5‐FU (RR 0.26, 95% CI 0.08 to 0.80; n = 103; <a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>) (<a href="./references#CD007281-fig-0028" title="">Analysis 6.4</a>). For the intrapatient study (<a href="./references#CD007281-bbs2-0007" title="PerrettCM , McGregorJM , WarwickJ , KarranP , LeighIM , ProbyCM , et al. Treatment of post‐transplant premalignant skin disease: a randomised intrapatient comparative study of 5‐fluorouracil cream and topical photodynamic therapy. British Journal of Dermatology2007;156(2):320‐8. [MEDLINE: 17223873] ">Perrett 2007</a>), there was no statistically significant difference in cosmetic outcome when MAL‐PDT was compared to 5‐FU (0/9 in the first group and 4/9 in the second group (Fisher's Exact P value = 0.08)). </p> <p>In one study (<a href="./references#CD007281-bbs2-0009" title="SalimS , LemanJA , McCollJH , ChapmanR , MortonCA . Randomised comparison of photodynamic therapy with topical 5‐fluorouracil in Bowen's disease. British Journal of Dermatology2003;148(3):539‐43. [MEDLINE: 12653747] ">Salim 2003</a>), 3/33 lesions treated with 5‐FU became ulcerated resulting in prominent scarring, with 0/33 lesions treated with ALA‐PDT demonstrating clinically obvious scarring at 12 months. </p> </section> <section id="CD007281-sec-0143"> <p><b>Consumer satisfaction with treatment modality, cosmesis, or pain at site</b></p> <p>There was no statistically significant difference in pain reported by participants treated with either MAL‐PDT compared to 5‐FU (RR 0.59, 95% CI 0.31 to 1.13; <a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>) or ALA‐PDT compared to 5‐FU (RR 1.11, 95% CI 0.71 to 1.73) (<a href="./references#CD007281-fig-0029" title="">Analysis 6.5</a>). </p> </section> <section id="CD007281-sec-0144"> <p><b>Adverse outcomes</b></p> <p>There was no statistically significant difference in adverse events reported in a study comparing MAL‐PDT versus 5‐FU (RR 0.82, 95% CI 0.63 to 1.05; <a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>) (<a href="./references#CD007281-fig-0030" title="">Analysis 6.6</a>). The most frequently reported treatment‐related local adverse events for 5‐FU were pain (10/30), erythema (10/30), burning sensation (2/30), crusting (4/30), stinging (2/30), application site reaction (1/30), irritation (4/30), itching (5/30), and hyperpigmentation (1/30). </p> <p>There were statistically significantly fewer adverse events in the ALA‐PDT group as compared to 5‐FU (0/33 in the first group and 12/33 in the second group (Fisher's Exact P value &lt; 0.001)) (<a href="./references#CD007281-bbs2-0009" title="SalimS , LemanJA , McCollJH , ChapmanR , MortonCA . Randomised comparison of photodynamic therapy with topical 5‐fluorouracil in Bowen's disease. British Journal of Dermatology2003;148(3):539‐43. [MEDLINE: 12653747] ">Salim 2003</a>). </p> <p>Three participants (five lesions) who were treated with 5‐FU developed 'widespread dermatitic reactions' over the entire treated limbs and withdrew from the study (<a href="./references#CD007281-bbs2-0009" title="SalimS , LemanJA , McCollJH , ChapmanR , MortonCA . Randomised comparison of photodynamic therapy with topical 5‐fluorouracil in Bowen's disease. British Journal of Dermatology2003;148(3):539‐43. [MEDLINE: 12653747] ">Salim 2003</a>). One participant (two lesions) developed a similar reaction but completed therapy. Three lesions ulcerated; two lesions developed into painful erosions on completion of the treatment cycle. Ulcerated lesions healed with prominent scarring (<a href="./references#CD007281-bbs2-0009" title="SalimS , LemanJA , McCollJH , ChapmanR , MortonCA . Randomised comparison of photodynamic therapy with topical 5‐fluorouracil in Bowen's disease. British Journal of Dermatology2003;148(3):539‐43. [MEDLINE: 12653747] ">Salim 2003</a>). </p> <p>In the intrapatient study (<a href="./references#CD007281-bbs2-0007" title="PerrettCM , McGregorJM , WarwickJ , KarranP , LeighIM , ProbyCM , et al. Treatment of post‐transplant premalignant skin disease: a randomised intrapatient comparative study of 5‐fluorouracil cream and topical photodynamic therapy. British Journal of Dermatology2007;156(2):320‐8. [MEDLINE: 17223873] ">Perrett 2007</a>), all participants experienced crusting of the treatment area following treatment with MAL‐PDT; 3/8 participants experienced pruritus; and 1/8 developed postinflammatory hyperpigmentation. Reported local reactions with 5‐FU included superficial erosions, crusting, and pruritus. This study did have a mixed population of people with actinic keratoses and Bowen's disease, and adverse events were not stratified according to skin lesion. </p> <p>With regard to the other secondary outcomes, there were no data for these.</p> </section> </section> </section> </section> <section id="CD007281-sec-0145"> <h4 class="title">Cryotherapy versus 5‐fluorouracil</h4> <p>One study (<a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>) compared cryotherapy to 5‐FU. </p> <section id="CD007281-sec-0146"> <h5 class="title">Primary outcomes</h5> <section id="CD007281-sec-0147"> <h6 class="title">Number of lesions that cleared after first treatment cycle</h6> <p>There was no statistical significant difference in the number of lesions that cleared after the first treatment cycle (RR 0.99, 95% CI 0.78 to 1.26) (<a href="./references#CD007281-fig-0031" title="">Analysis 7.1</a>). </p> </section> <section id="CD007281-sec-0148"> <h6 class="title">Recurrence at 12 months</h6> <p>There was no statistical significant difference in recurrence at 12 months (RR 1.48, 95% CI 0.53 to 4.17) (<a href="./references#CD007281-fig-0032" title="">Analysis 7.2</a>). </p> </section> </section> <section id="CD007281-sec-0149"> <h5 class="title">Secondary outcomes</h5> <section id="CD007281-sec-0150"> <h6 class="title">Number of lesions that cleared after each treatment cycle</h6> <p>There was no statistically significant difference in the number of lesions that cleared after the second treatment cycle when cryotherapy was compared to 5‐FU (RR 1.00, 95% CI 0.96 to 1.04) (<a href="./references#CD007281-fig-0033" title="">Analysis 7.3</a>). </p> </section> <section id="CD007281-sec-0151"> <h6 class="title">Number of treatment cycles needed to achieve clearance</h6> <p>Thirty‐six participants needed 2 treatment cycles to achieve clearance.</p> </section> <section id="CD007281-sec-0152"> <h6 class="title">Cosmetic outcome</h6> <p>There was no statistically significant difference in cosmetic outcome (RR 0.87, 95% CI 0.65 to 1.17) (<a href="./references#CD007281-fig-0034" title="">Analysis 7.4</a>). </p> </section> <section id="CD007281-sec-0153"> <h6 class="title">Consumer satisfaction with treatment modality, cosmesis, or pain at site</h6> <p>The cryotherapy group compared to 5‐FU experienced no statistically significant difference in pain (RR 0.73, 95% CI 0.39 to 1.38) (<a href="./references#CD007281-fig-0035" title="">Analysis 7.5</a>). </p> </section> <section id="CD007281-sec-0154"> <h6 class="title">Adverse outcome</h6> <p>The cryotherapy group compared to 5‐FU experienced statistically significantly fewer adverse events (RR 0.64, 95% CI 0.47 to 0.86; n = 112) (<a href="./references#CD007281-fig-0036" title="">Analysis 7.6</a>). </p> <p>With regard to the other secondary outcomes, there were no data given for these.</p> </section> </section> </section> <section id="CD007281-sec-0155"> <h4 class="title">Imiquimod</h4> <p>One study (<a href="./references#CD007281-bbs2-0006" title="PatelGK , GoodwinR , ChawlaM , LaidlerP , PricePE , FinlayAY , et al. Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): A randomised, double‐blind placebo‐controlled trial. Journal of the American Academy of Dermatology2006;54(6):1025‐32. [MEDLINE: 16713457] ">Patel 2006</a>) compared imiquimod cream to placebo. This study included pre‐ and post‐treatment biopsies of lesions. </p> <section id="CD007281-sec-0156"> <h5 class="title">Primary outcomes</h5> <section id="CD007281-sec-0157"> <h6 class="title">Number of lesions that cleared after the first treatment cycle</h6> <p>Statistically significantly more lesions cleared in the imiquimod group (9/15 lesions) compared to placebo (0/16) (Fisher's Exact P value &lt; 0.001). </p> </section> <section id="CD007281-sec-0158"> <h6 class="title">Recurrence at 12 months</h6> <p>The imiquimod group reported no recurrences at 12 months.</p> </section> </section> <section id="CD007281-sec-0159"> <h5 class="title">Secondary outcomes</h5> <section id="CD007281-sec-0160"> <h6 class="title">Number of lesions that cleared after each treatment cycle</h6> <p>See the results for our primary outcome after one treatment cycle.</p> </section> <section id="CD007281-sec-0161"> <h6 class="title">Number of treatment cycles needed to achieve clearance</h6> <p>Only one treatment cycle was given, so we could not determine this.</p> </section> <section id="CD007281-sec-0162"> <h6 class="title">Recurrence at &gt; 12 months</h6> <p>Follow‐up at 72 weeks revealed no recurrence in the imiquimod‐treated group. At 72 weeks, 2/16 participants in the placebo‐group had developed early invasive SCC. No statistical analysis was provided. </p> </section> <section id="CD007281-sec-0163"> <h6 class="title">Cosmetic outcome</h6> <p>Clinical resolution was reported to be 'often' associated with faint residual blanching erythema or postinflammatory hyperpigmentation, although actual numbers were not provided. </p> </section> <section id="CD007281-sec-0164"> <h6 class="title">Adverse outcomes</h6> <p>Almost all the participants treated with imiquimod developed a localised inflammatory reaction. Overall, 19 participants out of 31 experienced transient itching, oedema, or weeping. Four participants experienced adverse events related to the treatment, and 17 were deemed unrelated to the treatment. </p> <p>Histological assessment at the end of the trial revealed progression to early invasive squamous cell carcinoma in 2/16 participants in the placebo group. </p> <p>With regard to the other secondary outcomes, there were no data for these.</p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD007281-sec-0165" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD007281-sec-0165"></div> <section id="CD007281-sec-0166"> <h3 class="title" id="CD007281-sec-0166">Summary of main results</h3> <p>In summary, of our 9 included studies, which included 363 participants, the interventions included photodynamic therapy, cryotherapy, 5‐fluorouracil, and imiquimod. </p> <section id="CD007281-sec-0167"> <h4 class="title">Photodynamic therapy (PDT)</h4> <p>There was no statistically significant difference in clearance of lesions between ALA‐PDT (5‐aminolevulinic acid with photodynamic therapy) red light with ALA‐PDT green light, but there were significantly fewer recurrences at 12 months in those lesions treated with red light. There appears to be no superiority of ALA‐PDT two‐fold illumination versus single illumination (<a href="./references#CD007281-bbs2-0001" title="deHaasER , SterenborgHJ , NeumannHA , RobinsonDJ . Response of Bowen disease to ALA‐PDT using a single and a 2‐fold illumination scheme. Archives of Dermatology2007;143(2):264‐5. [MEDLINE: 17310011] ">de Haas 2007</a>; <a href="./references#CD007281-bbs2-0008" title="Puizina‐IvicN , ZorcH , Vanjaka‐RogosicL , MiricL , PersinA . Fractionated illumination improves the outcome in the treatment of precanerous lesions with photodynamic therapy. Collegium Antropologicum2008;32(Suppl 2):67‐73. [MEDLINE: 19138010] ">Puizina‐Ivic 2008</a>), nor between increased doses of red light with intravenous verteporfin (<a href="./references#CD007281-bbs2-0002" title="LuiH , BobbsL , TopeWD , LeePK , ElmetsC , ProvostN , et al. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light‐emitting diodes: two‐year results evaluating tumor response and cosmetic outcomes. Archives of Dermatology2004;140(1):26‐32. [MEDLINE: 14732656] ">Lui 2004</a>). There were no RCTs directly comparing treatment with ALA‐PDT versus MAL‐PDT (methyl aminolevulinate with photodynamic therapy). MAL‐PDT was significantly better at clearing lesions (103/111 lesions) compared with placebo‐PDT (12/24 lesions). Although participant tolerability was greater and cosmetic outcomes were considered significantly better in both MAL‐PDT and ALA‐PDT‐treated groups compared with cryotherapy, only MAL‐PDT appears to be significantly more effective in clearing the lesions of Bowen's disease (103/111 versus 73/85 lesions treated with cryotherapy) (<a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>). In both cases, freeze‐thaw cycles of 20 seconds were used. </p> <p>There was no difference in efficacy between MAL‐PDT and 5‐fluorouracil in the treatment of Bowen's disease in either immunocompetent (<a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>) or immunosuppressed (<a href="./references#CD007281-bbs2-0007" title="PerrettCM , McGregorJM , WarwickJ , KarranP , LeighIM , ProbyCM , et al. Treatment of post‐transplant premalignant skin disease: a randomised intrapatient comparative study of 5‐fluorouracil cream and topical photodynamic therapy. British Journal of Dermatology2007;156(2):320‐8. [MEDLINE: 17223873] ">Perrett 2007</a>) individuals. However, ALA‐PDT demonstrated significantly greater efficacy compared with 5‐fluorouracil (<a href="./references#CD007281-bbs2-0009" title="SalimS , LemanJA , McCollJH , ChapmanR , MortonCA . Randomised comparison of photodynamic therapy with topical 5‐fluorouracil in Bowen's disease. British Journal of Dermatology2003;148(3):539‐43. [MEDLINE: 12653747] ">Salim 2003</a> ), but there was no difference in recurrence rates at 12 months with either MAL‐PDT or ALA‐PDT when compared with 5‐fluorouracil. Longer‐term follow‐up studies are required. </p> </section> <section id="CD007281-sec-0168"> <h4 class="title">Cryotherapy</h4> <p>There was no difference in efficacy, recurrence rates, or cosmetic outcome between cryotherapy and 5‐fluorouracil (<a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>). </p> </section> <section id="CD007281-sec-0169"> <h4 class="title">5‐fluorouracil</h4> <p>5‐fluorouracil was as effective as PDT, but had significantly more adverse reactions than ALA‐PDT (<a href="./references#CD007281-bbs2-0009" title="SalimS , LemanJA , McCollJH , ChapmanR , MortonCA . Randomised comparison of photodynamic therapy with topical 5‐fluorouracil in Bowen's disease. British Journal of Dermatology2003;148(3):539‐43. [MEDLINE: 12653747] ">Salim 2003</a>) and caused significantly more pain than cryotherapy (<a href="./references#CD007281-bbs2-0005" title="MortonC , HornM , LemanJ , TackB , BedaneC , TjioeM , et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Archives of Dermatology2006;142(6):729‐35. [MEDLINE: 16785375] ">Morton 2006</a>). </p> </section> <section id="CD007281-sec-0170"> <h4 class="title">Imiquimod</h4> <p>Imiquimod was superior to placebo in clearing the lesions of Bowen's disease (<a href="./references#CD007281-bbs2-0006" title="PatelGK , GoodwinR , ChawlaM , LaidlerP , PricePE , FinlayAY , et al. Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): A randomised, double‐blind placebo‐controlled trial. Journal of the American Academy of Dermatology2006;54(6):1025‐32. [MEDLINE: 16713457] ">Patel 2006</a>). Histological examination post‐treatment demonstrated no recurrences at 72 weeks, but early invasive SCC was reported in the placebo‐treated group. Transient localised inflammatory reactions were commonly reported. There were no studies comparing imiquimod to other treatments. </p> </section> </section> <section id="CD007281-sec-0171"> <h3 class="title" id="CD007281-sec-0171">Overall completeness and applicability of evidence</h3> <p>In this review, we attempted to address the following:</p> <p>(1) What are the most effective treatments for Bowen's disease, with the fewest side‐effects?</p> <p>Specifically, the lack of quality data limited this systematic review, such that we only included nine randomised controlled studies, and seven of those involved photodynamic therapy (PDT). Therefore, the majority of evidence available for the treatment of Bowen's disease is PDT. However, surgery is the most common treatment for Bowen's, and topical treatments such as 5‐fluorouracil and imiquimod creams are more widely available, more frequently used, and cheaper than PDT. Moreover, there is considerable variation in the efficacy of PDT, which is operator‐dependent. There is clearly better evidence in terms of RCTs for the use of PDT in Bowen's disease, but the lack of evidence for topical creams and surgery does not necessarily equate to a lack of efficacy. The bias towards PDT rather limits the usefulness of this review for a general practitioner or dermatologist working in a clinic without PDT resources. The efficacy of cryotherapy is also operator‐dependent, and in both studies using cryotherapy, a 20‐second freeze‐thaw cycle was used. Variation in clinical practice exists, and this was not studied. </p> <p>(2) How do the various therapies compare in the following participant subgroups:</p> <p> <ul id="CD007281-list-0024"> <li> <p>participants with lower leg lesions (i.e. located below the knee)?</p> </li> <li> <p>participants with lesions &gt; 2 cm²?</p> </li> <li> <p>participants with medical comorbidities leading to poor wounding healing, age greater than 70 years, or both? </p> </li> </ul> </p> <p>Data for specific participant subgroups were not available from these studies. Only one study (<a href="./references#CD007281-bbs2-0004" title="MortonCA , WhitehurstC , MooreJV , MacKieRM . Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. British Journal of Dermatology2000;143(4):767‐72. [MEDLINE: 11069454] ">Morton 2000</a>) reported lesions exclusively located on the lower leg comparing red and green light with ALA‐PDT, and one study (<a href="./references#CD007281-bbs2-0009" title="SalimS , LemanJA , McCollJH , ChapmanR , MortonCA . Randomised comparison of photodynamic therapy with topical 5‐fluorouracil in Bowen's disease. British Journal of Dermatology2003;148(3):539‐43. [MEDLINE: 12653747] ">Salim 2003</a>) treated lesions on the legs only with PDT, but all sites were included in the 5‐fluorouracil‐treated arm. </p> <p>Retrospective analysis of lesions that were successfully treated with imiquimod found no difference in age, sex, lesion size, duration, lesion symptoms, lesion characteristics, or occurrence of adverse events between the nine participants who responded compared with those who did not, using Fishers exact test (<a href="./references#CD007281-bbs2-0006" title="PatelGK , GoodwinR , ChawlaM , LaidlerP , PricePE , FinlayAY , et al. Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): A randomised, double‐blind placebo‐controlled trial. Journal of the American Academy of Dermatology2006;54(6):1025‐32. [MEDLINE: 16713457] ">Patel 2006</a>). The small numbers in this study and the posthoc analysis is not able to provide any information for clinicians. </p> <p>None of the other studies assessed the impact of the site of Bowen's disease on response to treatment. </p> <p>None of the studies provided a subgroup analysis of lesions exceeding 2 cm², nor did any studies specifically report participants with medical comorbidities leading to poor wound healing, or those with an age greater than 70 years. </p> <p>Nevertheless, the review provides reassurance to clinicians that the treatments used have an evidence base, and hence options can be selected in a clinically relevant manner. Guidance is now available on which studies should be undertaken to generate the evidence needed. </p> </section> <section id="CD007281-sec-0172"> <h3 class="title" id="CD007281-sec-0172">Quality of the evidence</h3> <p>The quality of the evidence is limited in terms of the number of trials, number of participants in trials, and the treatment comparisons available. Available treatments, including photodynamic therapy, cryotherapy, 5‐fluorouracil, and imiquimod, appear to be effective, but firm conclusions about comparative effectiveness cannot be drawn. Because of the presentation of the findings of the studies, with variable lesions treated per participant, we had to expand our primary outcome to include the number of lesions. Therefore, because of the methods available in Review Manager, we were unable to take into account any clustering effects by participants even if reported, and thus the precision of the measures of effect are likely to be less conservative. </p> </section> <section id="CD007281-sec-0173"> <h3 class="title" id="CD007281-sec-0173">Potential biases in the review process</h3> <p>We identified no potential biases in relation to the review process.</p> </section> <section id="CD007281-sec-0174"> <h3 class="title" id="CD007281-sec-0174">Agreements and disagreements with other studies or reviews</h3> <p>This is the only systematic review available on this topic.</p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD007281-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD007281-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/full#CD007281-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study" data-id="CD007281-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/full#CD007281-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies" data-id="CD007281-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/full#CD007281-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 ALA‐PDT single versus 2‐fold illumination, Outcome 1 Number of lesions that cleared after first cycle of treatment." data-id="CD007281-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 ALA‐PDT single versus 2‐fold illumination, Outcome 1 Number of lesions that cleared after first cycle of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 ALA‐PDT single versus 2‐fold illumination, Outcome 2 Number of lesions with a good cosmetic outcome." data-id="CD007281-fig-0005" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 ALA‐PDT single versus 2‐fold illumination, Outcome 2 Number of lesions with a good cosmetic outcome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 ALA‐PDT single versus 2‐fold illumination, Outcome 3 Number of lesions treated in which pain reported and required lidocane." data-id="CD007281-fig-0006" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 ALA‐PDT single versus 2‐fold illumination, Outcome 3 Number of lesions treated in which pain reported and required lidocane. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 ALA‐PDT red light versus green light, Outcome 1 Number of lesions cleared after first cycle of treatment." data-id="CD007281-fig-0007" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 ALA‐PDT red light versus green light, Outcome 1 Number of lesions cleared after first cycle of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 ALA‐PDT red light versus green light, Outcome 2 Number of lesions that recurred at 12 months." data-id="CD007281-fig-0008" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 ALA‐PDT red light versus green light, Outcome 2 Number of lesions that recurred at 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 ALA‐PDT red light versus green light, Outcome 3 Numbers of lesions cleared second cycle." data-id="CD007281-fig-0009" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 ALA‐PDT red light versus green light, Outcome 3 Numbers of lesions cleared second cycle. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 ALA‐PDT red light versus green light, Outcome 4 Number of adverse outcomes (pain reported)." data-id="CD007281-fig-0010" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 ALA‐PDT red light versus green light, Outcome 4 Number of adverse outcomes (pain reported). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Verteporfin red light ‐ various doses, Outcome 1 60 J/cm² versus 120 J/cm²." data-id="CD007281-fig-0011" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Verteporfin red light ‐ various doses, Outcome 1 60 J/cm² versus 120 J/cm². </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Verteporfin red light ‐ various doses, Outcome 2 60 J/cm² versus 180 J/cm²." data-id="CD007281-fig-0012" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Verteporfin red light ‐ various doses, Outcome 2 60 J/cm² versus 180 J/cm². </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Verteporfin red light ‐ various doses, Outcome 3 120 J/cm² versus 180 J/cm²." data-id="CD007281-fig-0013" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Verteporfin red light ‐ various doses, Outcome 3 120 J/cm² versus 180 J/cm². </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Photodynamic therapy versus placebo, Outcome 1 Number of lesions cleared after first treatment cycle." data-id="CD007281-fig-0014" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Photodynamic therapy versus placebo, Outcome 1 Number of lesions cleared after first treatment cycle. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Photodynamic therapy versus placebo, Outcome 2 Number of lesions that recurred at 12 months." data-id="CD007281-fig-0015" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Photodynamic therapy versus placebo, Outcome 2 Number of lesions that recurred at 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Photodynamic therapy versus placebo, Outcome 3 Number of lesions cleared after second treatment cycle." data-id="CD007281-fig-0016" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Photodynamic therapy versus placebo, Outcome 3 Number of lesions cleared after second treatment cycle. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Photodynamic therapy versus placebo, Outcome 4 Number of participants treated reporting pain." data-id="CD007281-fig-0017" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Photodynamic therapy versus placebo, Outcome 4 Number of participants treated reporting pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Photodynamic therapy versus placebo, Outcome 5 Number of adverse events &gt; = 1 in participants." data-id="CD007281-fig-0018" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Photodynamic therapy versus placebo, Outcome 5 Number of adverse events &gt; = 1 in participants. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Photodynamic therapy versus cryotherapy, Outcome 1 Number of lesions that cleared after first cycle of treatment." data-id="CD007281-fig-0019" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Photodynamic therapy versus cryotherapy, Outcome 1 Number of lesions that cleared after first cycle of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Photodynamic therapy versus cryotherapy, Outcome 2 Recurrence at 12 months." data-id="CD007281-fig-0020" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Photodynamic therapy versus cryotherapy, Outcome 2 Recurrence at 12 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Photodynamic therapy versus cryotherapy, Outcome 3 Number of lesions that cleared after second treatment cycle." data-id="CD007281-fig-0021" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Photodynamic therapy versus cryotherapy, Outcome 3 Number of lesions that cleared after second treatment cycle. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Photodynamic therapy versus cryotherapy, Outcome 4 Number of participants with a good cosmetic outcome (12 months)." data-id="CD007281-fig-0022" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Photodynamic therapy versus cryotherapy, Outcome 4 Number of participants with a good cosmetic outcome (12 months). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Photodynamic therapy versus cryotherapy, Outcome 5 Number of lesions treated where pain is reported." data-id="CD007281-fig-0023" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Photodynamic therapy versus cryotherapy, Outcome 5 Number of lesions treated where pain is reported. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Photodynamic therapy versus cryotherapy, Outcome 6 Number of adverse events &gt; = 1 in participants." data-id="CD007281-fig-0024" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 Photodynamic therapy versus cryotherapy, Outcome 6 Number of adverse events &gt; = 1 in participants. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Photodynamic therapy versus 5‐FU, Outcome 1 Number of lesions cleared after first treatment cycle." data-id="CD007281-fig-0025" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Photodynamic therapy versus 5‐FU, Outcome 1 Number of lesions cleared after first treatment cycle. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Photodynamic therapy versus 5‐FU, Outcome 2 Recurrence &gt; 12 months." data-id="CD007281-fig-0026" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Photodynamic therapy versus 5‐FU, Outcome 2 Recurrence &gt; 12 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Photodynamic therapy versus 5‐FU, Outcome 3 Number of lesions that cleared after second treatment cycle." data-id="CD007281-fig-0027" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Photodynamic therapy versus 5‐FU, Outcome 3 Number of lesions that cleared after second treatment cycle. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Photodynamic therapy versus 5‐FU, Outcome 4 Number of participants with a good cosmetic outcome." data-id="CD007281-fig-0028" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 Photodynamic therapy versus 5‐FU, Outcome 4 Number of participants with a good cosmetic outcome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-006-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-006-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Photodynamic therapy versus 5‐FU, Outcome 5 Number of participants treated reporting pain." data-id="CD007281-fig-0029" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-006-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6 Photodynamic therapy versus 5‐FU, Outcome 5 Number of participants treated reporting pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-006-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-006-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-006-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Photodynamic therapy versus 5‐FU, Outcome 6 Number of adverse events." data-id="CD007281-fig-0030" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-006-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6 Photodynamic therapy versus 5‐FU, Outcome 6 Number of adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-006-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Cryotherapy versus 5‐FU, Outcome 1 Number of lesions that cleared after first cycle of treatment." data-id="CD007281-fig-0031" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Cryotherapy versus 5‐FU, Outcome 1 Number of lesions that cleared after first cycle of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Cryotherapy versus 5‐FU, Outcome 2 Recurrence at 12 months." data-id="CD007281-fig-0032" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Cryotherapy versus 5‐FU, Outcome 2 Recurrence at 12 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Cryotherapy versus 5‐FU, Outcome 3 Number of lesions that cleared after second cycle of treatment." data-id="CD007281-fig-0033" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Cryotherapy versus 5‐FU, Outcome 3 Number of lesions that cleared after second cycle of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-007-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-007-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Cryotherapy versus 5‐FU, Outcome 4 Number of participants with a good/excellent cosmetic outcome." data-id="CD007281-fig-0034" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-007-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 Cryotherapy versus 5‐FU, Outcome 4 Number of participants with a good/excellent cosmetic outcome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-007-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-007-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-007-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Cryotherapy versus 5‐FU, Outcome 5 Number of participants treated reporting pain." data-id="CD007281-fig-0035" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-007-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.5</div> <div class="figure-caption"> <p>Comparison 7 Cryotherapy versus 5‐FU, Outcome 5 Number of participants treated reporting pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-007-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007281-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/urn:x-wiley:14651858:media:CD007281:CD007281-CMP-007-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_t/tCD007281-CMP-007-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Cryotherapy versus 5‐FU, Outcome 6 Number of adverse events &gt; = 1." data-id="CD007281-fig-0036" src="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-007-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.6</div> <div class="figure-caption"> <p>Comparison 7 Cryotherapy versus 5‐FU, Outcome 6 Number of adverse events &gt; = 1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/media/CDSR/CD007281/image_n/nCD007281-CMP-007-06.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD007281-tbl-0001"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Glossary of terms</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Medical term</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Explanation</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Metastasis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The spread of a malignant tumour from its original site to another part of the body, e.g. lungs, lymph nodes, liver, brain, bones, etc </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Epidermis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The outermost layer of the skin</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Transformation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A process by which cells acquire the properties of cancer</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Subungual</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Underneath the nail (finger or toe)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Periungual</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Around the nail</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Carcinogen</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This is any substance, radionuclide, or radiation that is an agent directly involved in causing cancer </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HPV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human papillomavirus</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TH1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>T‐helper cells 1</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>T cell</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A type of white blood cell</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Glossary of terms</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/full#CD007281-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007281-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">ALA‐PDT single versus 2‐fold illumination</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Number of lesions that cleared after first cycle of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.62, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Number of lesions with a good cosmetic outcome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Number of lesions treated in which pain reported and required lidocane <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">ALA‐PDT single versus 2‐fold illumination</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007281-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">ALA‐PDT red light versus green light</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Number of lesions cleared after first cycle of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Number of lesions that recurred at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Numbers of lesions cleared second cycle <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Two cycles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Number of adverse outcomes (pain reported) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">ALA‐PDT red light versus green light</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007281-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Verteporfin red light ‐ various doses</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 60 J/cm² versus 120 J/cm² <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Number of lesions that cleared after one treatment cycle</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 60 J/cm² versus 180 J/cm² <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Number of lesions that cleared after one treatment cycle</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 120 J/cm² versus 180 J/cm² <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Number of lesions that cleared after one treatment cycle</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Verteporfin red light ‐ various doses</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007281-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Photodynamic therapy versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Number of lesions cleared after first treatment cycle <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Mal‐PDT versus placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Number of lesions that recurred at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Mal‐PDT versus placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Number of lesions cleared after second treatment cycle <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Two treatment cycles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Number of participants treated reporting pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 MAL‐PDT versus placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Number of adverse events &gt; = 1 in participants <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 MAL‐PDT versus placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Photodynamic therapy versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007281-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Photodynamic therapy versus cryotherapy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Number of lesions that cleared after first cycle of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 MAL‐PDT versus cryotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 ALA‐PDT versus cryotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Recurrence at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 MAL‐PDT versus cryotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Number of lesions that cleared after second treatment cycle <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 MAL‐PDT versus cryotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 ALA‐PDT versus cryotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Number of participants with a good cosmetic outcome (12 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 MAL‐PDT versus cryotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Number of lesions treated where pain is reported <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 MAL‐PDT versus cryotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 ALA‐PDT versus cryotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Number of adverse events &gt; = 1 in participants <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 MAL‐PDT versus cryotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Photodynamic therapy versus cryotherapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007281-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Photodynamic therapy versus 5‐FU</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Number of lesions cleared after first treatment cycle <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 MAL‐PDT versus 5‐FU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 ALA‐PDT versus 5‐FU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 MAL‐PDT versus 5‐FU (intraparticipant)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Recurrence &gt; 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 MAL‐PDT versus 5‐FU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 ALA‐PDT versus 5‐FU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Number of lesions that cleared after second treatment cycle <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Two cycles (MAL‐PDT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Two cycles (ALA‐PDT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Number of participants with a good cosmetic outcome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 MAL‐PDT versus 5‐FU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Number of participants treated reporting pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 MAL‐PDT versus 5‐FU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 ALA‐PDT versus 5‐FU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Number of adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 MAL‐PDT versus 5‐FU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Photodynamic therapy versus 5‐FU</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007281-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Cryotherapy versus 5‐FU</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Number of lesions that cleared after first cycle of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Recurrence at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Number of lesions that cleared after second cycle of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Number of participants with a good/excellent cosmetic outcome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Number of participants treated reporting pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Number of adverse events &gt; = 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Cryotherapy versus 5‐FU</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007281.pub2/references#CD007281-tbl-0008">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD007281.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD007281-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD007281-note-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD007281-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD007281-note-0001">Hrvatski</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD007281-note-0006">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007281\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007281\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007281\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007281\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007281\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007281\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007281\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007281\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007281\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007281\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007281\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007281\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007281\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007281\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007281\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007281\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007281\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007281\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=9mpoajSI&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007281.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007281.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD007281.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD007281.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007281.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740728270417"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007281.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740728270421"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007281.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ec05f78acf46e',t:'MTc0MDcyODI3MC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 